| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Charcot-Marie-Tooth Disease | 102 | 2023 | 219 | 11.510 |
Why?
|
| Chromosomes, Human, Pair 17 | 119 | 2021 | 362 | 10.400 |
Why?
|
| DNA Copy Number Variations | 88 | 2025 | 1004 | 9.930 |
Why?
|
| Genome, Human | 82 | 2025 | 1279 | 9.050 |
Why?
|
| Mutation | 220 | 2025 | 5941 | 8.560 |
Why?
|
| Intellectual Disability | 91 | 2025 | 1048 | 8.240 |
Why?
|
| Phenotype | 220 | 2026 | 4304 | 7.460 |
Why?
|
| Genetic Diseases, Inborn | 44 | 2025 | 459 | 7.370 |
Why?
|
| Gene Duplication | 71 | 2024 | 363 | 7.060 |
Why?
|
| Pedigree | 201 | 2025 | 1656 | 6.820 |
Why?
|
| Neurodevelopmental Disorders | 36 | 2026 | 526 | 6.620 |
Why?
|
| Abnormalities, Multiple | 90 | 2022 | 964 | 6.510 |
Why?
|
| Gene Dosage | 62 | 2025 | 436 | 6.290 |
Why?
|
| Gene Rearrangement | 47 | 2020 | 321 | 6.280 |
Why?
|
| Exome | 74 | 2025 | 1064 | 5.900 |
Why?
|
| Chromosome Aberrations | 52 | 2024 | 570 | 5.510 |
Why?
|
| Genetic Variation | 57 | 2025 | 1508 | 5.300 |
Why?
|
| Genetic Predisposition to Disease | 82 | 2025 | 3262 | 5.180 |
Why?
|
| Alleles | 85 | 2025 | 1609 | 5.020 |
Why?
|
| Genomics | 48 | 2025 | 1546 | 4.570 |
Why?
|
| Genetic Association Studies | 48 | 2024 | 808 | 4.370 |
Why?
|
| Gene Deletion | 51 | 2017 | 767 | 4.050 |
Why?
|
| Microcephaly | 30 | 2025 | 343 | 4.000 |
Why?
|
| Membrane Proteins | 45 | 2024 | 1569 | 3.940 |
Why?
|
| Humans | 790 | 2026 | 126754 | 3.820 |
Why?
|
| Chromosome Deletion | 57 | 2019 | 642 | 3.730 |
Why?
|
| Comparative Genomic Hybridization | 69 | 2024 | 560 | 3.660 |
Why?
|
| Recombination, Genetic | 41 | 2019 | 418 | 3.510 |
Why?
|
| DNA Replication | 33 | 2022 | 347 | 3.500 |
Why?
|
| Base Sequence | 123 | 2022 | 2757 | 3.420 |
Why?
|
| Mutation, Missense | 58 | 2026 | 891 | 3.260 |
Why?
|
| Myelin Proteins | 31 | 2016 | 74 | 3.230 |
Why?
|
| Sequence Analysis, DNA | 66 | 2021 | 1707 | 3.200 |
Why?
|
| Genetics, Medical | 9 | 2025 | 116 | 3.120 |
Why?
|
| Molecular Sequence Data | 121 | 2016 | 3584 | 2.970 |
Why?
|
| Translocation, Genetic | 27 | 2024 | 348 | 2.960 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 40 | 2019 | 348 | 2.950 |
Why?
|
| Chromosome Disorders | 37 | 2020 | 315 | 2.930 |
Why?
|
| Male | 429 | 2026 | 62543 | 2.870 |
Why?
|
| Homozygote | 41 | 2024 | 540 | 2.860 |
Why?
|
| Nervous System Diseases | 13 | 2023 | 393 | 2.810 |
Why?
|
| Chromosome Mapping | 88 | 2019 | 1054 | 2.740 |
Why?
|
| Sequence Deletion | 39 | 2021 | 510 | 2.660 |
Why?
|
| Developmental Disabilities | 34 | 2025 | 718 | 2.660 |
Why?
|
| Female | 426 | 2026 | 68330 | 2.650 |
Why?
|
| Genomic Instability | 21 | 2022 | 239 | 2.640 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 24 | 2013 | 38 | 2.610 |
Why?
|
| Nuclear Proteins | 25 | 2025 | 1204 | 2.510 |
Why?
|
| Craniofacial Abnormalities | 21 | 2022 | 252 | 2.510 |
Why?
|
| Proteins | 30 | 2020 | 1018 | 2.450 |
Why?
|
| Smith-Magenis Syndrome | 19 | 2020 | 107 | 2.400 |
Why?
|
| Peripheral Nervous System Diseases | 20 | 2018 | 130 | 2.390 |
Why?
|
| Mosaicism | 23 | 2022 | 230 | 2.370 |
Why?
|
| Child, Preschool | 182 | 2026 | 14347 | 2.360 |
Why?
|
| Alu Elements | 9 | 2021 | 67 | 2.320 |
Why?
|
| Myelin Proteolipid Protein | 11 | 2019 | 27 | 2.260 |
Why?
|
| Transcription Factors | 43 | 2024 | 2337 | 2.250 |
Why?
|
| ATP-Binding Cassette Transporters | 20 | 2024 | 189 | 2.240 |
Why?
|
| Genes, Recessive | 32 | 2022 | 184 | 2.200 |
Why?
|
| In Situ Hybridization, Fluorescence | 76 | 2022 | 748 | 2.180 |
Why?
|
| Evolution, Molecular | 22 | 2015 | 651 | 2.170 |
Why?
|
| Polymorphism, Single Nucleotide | 46 | 2025 | 2746 | 2.140 |
Why?
|
| Chromosome Duplication | 25 | 2024 | 147 | 2.100 |
Why?
|
| Pelizaeus-Merzbacher Disease | 12 | 2017 | 21 | 2.070 |
Why?
|
| Heterozygote | 38 | 2025 | 690 | 2.050 |
Why?
|
| Syndrome | 69 | 2023 | 1137 | 2.050 |
Why?
|
| Exons | 41 | 2020 | 757 | 2.000 |
Why?
|
| DNA-Binding Proteins | 40 | 2025 | 1877 | 1.950 |
Why?
|
| Models, Genetic | 33 | 2019 | 742 | 1.900 |
Why?
|
| Awards and Prizes | 5 | 2025 | 64 | 1.890 |
Why?
|
| Child | 208 | 2026 | 25101 | 1.860 |
Why?
|
| Infant | 126 | 2026 | 12771 | 1.840 |
Why?
|
| Epilepsy | 14 | 2024 | 844 | 1.820 |
Why?
|
| Bardet-Biedl Syndrome | 16 | 2016 | 37 | 1.790 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 17 | 2024 | 578 | 1.780 |
Why?
|
| Animals | 187 | 2025 | 33051 | 1.770 |
Why?
|
| Multigene Family | 26 | 2011 | 289 | 1.750 |
Why?
|
| Scoliosis | 11 | 2025 | 140 | 1.750 |
Why?
|
| Cerebellar Diseases | 5 | 2025 | 77 | 1.720 |
Why?
|
| Genetic Testing | 29 | 2024 | 1056 | 1.720 |
Why?
|
| Trans-Activators | 20 | 2021 | 675 | 1.720 |
Why?
|
| DNA Mutational Analysis | 59 | 2019 | 781 | 1.710 |
Why?
|
| Urogenital Abnormalities | 10 | 2023 | 160 | 1.710 |
Why?
|
| Polymerase Chain Reaction | 47 | 2020 | 1479 | 1.670 |
Why?
|
| Adolescent | 153 | 2026 | 20002 | 1.620 |
Why?
|
| Epilepsy, Generalized | 4 | 2023 | 61 | 1.580 |
Why?
|
| Chromosomes, Human, X | 11 | 2024 | 150 | 1.580 |
Why?
|
| Demyelinating Diseases | 14 | 2018 | 65 | 1.570 |
Why?
|
| Chromosome Breakage | 24 | 2016 | 156 | 1.540 |
Why?
|
| Point Mutation | 26 | 2017 | 334 | 1.540 |
Why?
|
| Penetrance | 10 | 2025 | 106 | 1.540 |
Why?
|
| Databases, Genetic | 15 | 2024 | 481 | 1.510 |
Why?
|
| Genomic Structural Variation | 10 | 2025 | 93 | 1.500 |
Why?
|
| Genes, Dominant | 24 | 2020 | 241 | 1.500 |
Why?
|
| Immunologic Deficiency Syndromes | 12 | 2025 | 209 | 1.500 |
Why?
|
| Amino Acid Sequence | 64 | 2025 | 2541 | 1.490 |
Why?
|
| Nerve Tissue Proteins | 18 | 2024 | 1098 | 1.470 |
Why?
|
| Disease | 8 | 2016 | 123 | 1.470 |
Why?
|
| DNA | 44 | 2022 | 1419 | 1.470 |
Why?
|
| Cell Cycle Proteins | 18 | 2020 | 677 | 1.450 |
Why?
|
| De Lange Syndrome | 7 | 2020 | 43 | 1.440 |
Why?
|
| Macular Degeneration | 14 | 2015 | 89 | 1.440 |
Why?
|
| Genotype | 60 | 2024 | 2595 | 1.430 |
Why?
|
| Muscle Hypotonia | 12 | 2021 | 188 | 1.410 |
Why?
|
| Molecular Diagnostic Techniques | 9 | 2019 | 167 | 1.380 |
Why?
|
| Adult | 154 | 2025 | 30410 | 1.350 |
Why?
|
| Myelin P0 Protein | 13 | 2015 | 25 | 1.340 |
Why?
|
| Genetic Linkage | 26 | 2019 | 463 | 1.310 |
Why?
|
| Retinal Diseases | 12 | 2016 | 144 | 1.300 |
Why?
|
| Mitochondrial Proteins | 9 | 2021 | 272 | 1.260 |
Why?
|
| Chromosomes, Human, Pair 2 | 6 | 2024 | 119 | 1.250 |
Why?
|
| Zebrafish | 26 | 2025 | 402 | 1.250 |
Why?
|
| Codon, Nonsense | 13 | 2021 | 139 | 1.230 |
Why?
|
| Mice | 102 | 2024 | 17596 | 1.220 |
Why?
|
| Genetic Markers | 27 | 2019 | 599 | 1.220 |
Why?
|
| Homologous Recombination | 13 | 2022 | 99 | 1.210 |
Why?
|
| Cohort Studies | 51 | 2026 | 4954 | 1.210 |
Why?
|
| Brain | 22 | 2025 | 3038 | 1.210 |
Why?
|
| T-Box Domain Proteins | 11 | 2022 | 110 | 1.210 |
Why?
|
| Dwarfism | 9 | 2022 | 102 | 1.210 |
Why?
|
| Chromosomes, Human, Pair 14 | 8 | 2019 | 96 | 1.200 |
Why?
|
| Inheritance Patterns | 15 | 2020 | 129 | 1.190 |
Why?
|
| Consanguinity | 19 | 2022 | 118 | 1.190 |
Why?
|
| Escherichia coli | 31 | 2009 | 962 | 1.190 |
Why?
|
| Crossing Over, Genetic | 9 | 2011 | 51 | 1.170 |
Why?
|
| Chromosomes, Human, Pair 9 | 9 | 2018 | 109 | 1.160 |
Why?
|
| 46, XX Disorders of Sex Development | 3 | 2023 | 26 | 1.140 |
Why?
|
| Disease Models, Animal | 35 | 2024 | 4429 | 1.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 13 | 2024 | 576 | 1.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 24 | 2020 | 899 | 1.100 |
Why?
|
| Family | 17 | 2021 | 575 | 1.080 |
Why?
|
| Neoplasm Proteins | 9 | 2023 | 652 | 1.080 |
Why?
|
| Carrier Proteins | 17 | 2024 | 1011 | 1.070 |
Why?
|
| Autistic Disorder | 13 | 2023 | 363 | 1.060 |
Why?
|
| Human Genetics | 2 | 2025 | 8 | 1.060 |
Why?
|
| Atrophy | 7 | 2023 | 237 | 1.060 |
Why?
|
| Polyneuropathies | 10 | 2018 | 30 | 1.040 |
Why?
|
| DNA Repair | 13 | 2020 | 549 | 1.030 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 11 | 2024 | 271 | 1.030 |
Why?
|
| Adenosine Triphosphatases | 6 | 2017 | 186 | 1.020 |
Why?
|
| Killer Cells, Natural | 10 | 2025 | 333 | 1.000 |
Why?
|
| High Mobility Group Proteins | 9 | 2007 | 31 | 0.990 |
Why?
|
| Frameshift Mutation | 15 | 2023 | 190 | 0.980 |
Why?
|
| Anodontia | 5 | 2018 | 30 | 0.970 |
Why?
|
| Limb Deformities, Congenital | 9 | 2022 | 109 | 0.960 |
Why?
|
| Transcription, Genetic | 13 | 2016 | 1377 | 0.960 |
Why?
|
| Microtubule-Associated Proteins | 17 | 2023 | 247 | 0.960 |
Why?
|
| Segmental Duplications, Genomic | 11 | 2015 | 81 | 0.950 |
Why?
|
| Retinitis Pigmentosa | 8 | 2018 | 89 | 0.950 |
Why?
|
| Young Adult | 58 | 2025 | 9665 | 0.930 |
Why?
|
| Software | 8 | 2025 | 711 | 0.930 |
Why?
|
| Repressor Proteins | 10 | 2022 | 761 | 0.930 |
Why?
|
| Heart Defects, Congenital | 15 | 2025 | 1853 | 0.930 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 26 | 2014 | 999 | 0.930 |
Why?
|
| Genome | 10 | 2020 | 464 | 0.930 |
Why?
|
| Nervous System Malformations | 6 | 2024 | 119 | 0.920 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2023 | 26 | 0.920 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2024 | 58 | 0.920 |
Why?
|
| Haplotypes | 19 | 2024 | 525 | 0.910 |
Why?
|
| Trisomy | 10 | 2017 | 107 | 0.900 |
Why?
|
| Multifactorial Inheritance | 6 | 2019 | 158 | 0.880 |
Why?
|
| Nonsense Mediated mRNA Decay | 3 | 2021 | 37 | 0.880 |
Why?
|
| Pathology, Molecular | 5 | 2018 | 63 | 0.880 |
Why?
|
| Rare Diseases | 7 | 2024 | 201 | 0.880 |
Why?
|
| Receptors, G-Protein-Coupled | 6 | 2024 | 291 | 0.880 |
Why?
|
| RNA Nucleotidyltransferases | 13 | 1997 | 32 | 0.870 |
Why?
|
| Language Development Disorders | 11 | 2020 | 177 | 0.870 |
Why?
|
| Receptors, Cell Surface | 9 | 2024 | 422 | 0.870 |
Why?
|
| Clinical Laboratory Techniques | 5 | 2020 | 146 | 0.860 |
Why?
|
| Cell Line | 28 | 2024 | 2560 | 0.860 |
Why?
|
| Patient Care | 2 | 2023 | 99 | 0.830 |
Why?
|
| Spasms, Infantile | 4 | 2019 | 165 | 0.830 |
Why?
|
| Genetic Diseases, X-Linked | 4 | 2016 | 78 | 0.830 |
Why?
|
| Calcium Channels | 4 | 2019 | 147 | 0.830 |
Why?
|
| Movement Disorders | 5 | 2024 | 221 | 0.830 |
Why?
|
| Telomere | 7 | 2012 | 206 | 0.820 |
Why?
|
| Chromosomes | 5 | 2020 | 118 | 0.820 |
Why?
|
| Arthrogryposis | 3 | 2022 | 36 | 0.810 |
Why?
|
| Congenital Abnormalities | 8 | 2023 | 300 | 0.800 |
Why?
|
| Nucleic Acid Hybridization | 14 | 2014 | 297 | 0.790 |
Why?
|
| Hand Deformities, Congenital | 4 | 2021 | 95 | 0.790 |
Why?
|
| Founder Effect | 5 | 2020 | 34 | 0.790 |
Why?
|
| Genetic Heterogeneity | 10 | 2024 | 129 | 0.790 |
Why?
|
| Growth Disorders | 6 | 2015 | 183 | 0.780 |
Why?
|
| Diploidy | 2 | 2022 | 36 | 0.780 |
Why?
|
| Infant, Newborn | 51 | 2025 | 8347 | 0.770 |
Why?
|
| Loss of Function Mutation | 9 | 2024 | 151 | 0.770 |
Why?
|
| Kidney Diseases, Cystic | 3 | 2022 | 44 | 0.770 |
Why?
|
| DNA Transposable Elements | 14 | 2001 | 175 | 0.750 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.750 |
Why?
|
| RNA-Binding Proteins | 9 | 2022 | 533 | 0.740 |
Why?
|
| Primary Ovarian Insufficiency | 2 | 2019 | 37 | 0.740 |
Why?
|
| Sequence Homology, Nucleic Acid | 12 | 2010 | 251 | 0.740 |
Why?
|
| DNA, Bacterial | 21 | 2005 | 482 | 0.740 |
Why?
|
| Genetic Loci | 7 | 2015 | 342 | 0.730 |
Why?
|
| Mental Disorders | 6 | 2015 | 860 | 0.730 |
Why?
|
| Chromosome Breakpoints | 11 | 2019 | 81 | 0.730 |
Why?
|
| Genes, Bacterial | 17 | 1997 | 215 | 0.720 |
Why?
|
| Gene Expression Regulation | 18 | 2025 | 2304 | 0.720 |
Why?
|
| Genomic Imprinting | 3 | 2019 | 127 | 0.720 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 10 | 0.720 |
Why?
|
| History, 21st Century | 6 | 2025 | 264 | 0.710 |
Why?
|
| Malformations of Cortical Development | 3 | 2018 | 53 | 0.700 |
Why?
|
| AlkB Homolog 8, tRNA Methyltransferase | 1 | 2021 | 5 | 0.690 |
Why?
|
| Zebrafish Proteins | 7 | 2025 | 121 | 0.690 |
Why?
|
| Haploinsufficiency | 12 | 2023 | 265 | 0.680 |
Why?
|
| Sequence Alignment | 16 | 2020 | 585 | 0.680 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2022 | 205 | 0.670 |
Why?
|
| Seizures | 15 | 2025 | 847 | 0.670 |
Why?
|
| Cerebellar Ataxia | 5 | 2023 | 69 | 0.670 |
Why?
|
| Germ-Line Mutation | 9 | 2017 | 352 | 0.670 |
Why?
|
| Mutagenesis | 3 | 2015 | 332 | 0.670 |
Why?
|
| Mitochondria | 4 | 2021 | 730 | 0.660 |
Why?
|
| Symporters | 1 | 2021 | 73 | 0.660 |
Why?
|
| Genetics | 2 | 2019 | 24 | 0.650 |
Why?
|
| Gigantism | 6 | 2016 | 14 | 0.650 |
Why?
|
| Chromosomes, Human, Pair 11 | 6 | 2011 | 87 | 0.650 |
Why?
|
| Actins | 7 | 2024 | 311 | 0.650 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 80 | 0.640 |
Why?
|
| Chromosomes, Human, Pair 1 | 8 | 2012 | 144 | 0.640 |
Why?
|
| Spastic Paraplegia, Hereditary | 3 | 2022 | 29 | 0.640 |
Why?
|
| Computational Biology | 10 | 2021 | 834 | 0.640 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 43 | 0.640 |
Why?
|
| Genome-Wide Association Study | 16 | 2018 | 1728 | 0.630 |
Why?
|
| DNA Fingerprinting | 12 | 2002 | 104 | 0.630 |
Why?
|
| GTP Phosphohydrolases | 7 | 2019 | 157 | 0.630 |
Why?
|
| Gene Frequency | 14 | 2024 | 737 | 0.630 |
Why?
|
| Waardenburg Syndrome | 5 | 2017 | 10 | 0.630 |
Why?
|
| Facies | 11 | 2021 | 156 | 0.630 |
Why?
|
| Cytoskeletal Proteins | 12 | 2024 | 273 | 0.620 |
Why?
|
| Histone-Lysine N-Methyltransferase | 9 | 2021 | 156 | 0.620 |
Why?
|
| Connexins | 8 | 2012 | 55 | 0.610 |
Why?
|
| Molecular Chaperones | 8 | 2023 | 169 | 0.600 |
Why?
|
| Chromosomes, Human, Pair 16 | 8 | 2019 | 147 | 0.600 |
Why?
|
| Curcumin | 3 | 2013 | 43 | 0.590 |
Why?
|
| Optic Atrophies, Hereditary | 2 | 2014 | 16 | 0.580 |
Why?
|
| Chromosome Inversion | 7 | 2020 | 73 | 0.580 |
Why?
|
| SOXE Transcription Factors | 8 | 2017 | 15 | 0.580 |
Why?
|
| Chromosomes, Human, Pair 22 | 9 | 2017 | 97 | 0.570 |
Why?
|
| Phosphoproteins | 5 | 2026 | 420 | 0.570 |
Why?
|
| Sequence Homology, Amino Acid | 20 | 2016 | 622 | 0.570 |
Why?
|
| Hirschsprung Disease | 5 | 2017 | 35 | 0.570 |
Why?
|
| DiGeorge Syndrome | 7 | 2012 | 79 | 0.570 |
Why?
|
| Uniparental Disomy | 4 | 2021 | 40 | 0.560 |
Why?
|
| Precision Medicine | 3 | 2016 | 345 | 0.560 |
Why?
|
| Drosophila melanogaster | 9 | 2024 | 808 | 0.550 |
Why?
|
| Retina | 10 | 2022 | 445 | 0.550 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2019 | 103 | 0.550 |
Why?
|
| Fibromatosis, Gingival | 1 | 2017 | 4 | 0.540 |
Why?
|
| Prenatal Diagnosis | 7 | 2009 | 631 | 0.540 |
Why?
|
| Arabs | 2 | 2016 | 29 | 0.530 |
Why?
|
| Amino Acid Substitution | 12 | 2020 | 398 | 0.530 |
Why?
|
| Cell Division | 7 | 2024 | 720 | 0.530 |
Why?
|
| Drosophila Proteins | 8 | 2024 | 757 | 0.520 |
Why?
|
| Turkey | 8 | 2021 | 64 | 0.520 |
Why?
|
| Leber Congenital Amaurosis | 3 | 2011 | 34 | 0.510 |
Why?
|
| Conserved Sequence | 9 | 2004 | 279 | 0.510 |
Why?
|
| Leadership | 1 | 2019 | 235 | 0.510 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 359 | 0.510 |
Why?
|
| RNA, Messenger | 16 | 2022 | 2537 | 0.500 |
Why?
|
| Eye Abnormalities | 5 | 2022 | 98 | 0.500 |
Why?
|
| Bacterial Typing Techniques | 6 | 2005 | 100 | 0.500 |
Why?
|
| Glaucoma | 5 | 2006 | 77 | 0.500 |
Why?
|
| B-Lymphocytes | 7 | 2025 | 515 | 0.500 |
Why?
|
| Early Growth Response Protein 2 | 7 | 2007 | 9 | 0.500 |
Why?
|
| Transcriptome | 3 | 2024 | 1052 | 0.490 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 4 | 2021 | 79 | 0.490 |
Why?
|
| Chromosomes, Human | 7 | 2017 | 121 | 0.490 |
Why?
|
| Polymorphism, Genetic | 15 | 2014 | 785 | 0.490 |
Why?
|
| INDEL Mutation | 4 | 2020 | 91 | 0.490 |
Why?
|
| Megalencephaly | 5 | 2022 | 59 | 0.490 |
Why?
|
| X Chromosome | 12 | 2014 | 327 | 0.480 |
Why?
|
| Siblings | 4 | 2024 | 202 | 0.480 |
Why?
|
| Alopecia | 2 | 2023 | 40 | 0.480 |
Why?
|
| Escherichia coli Proteins | 7 | 2007 | 297 | 0.480 |
Why?
|
| Age of Onset | 15 | 2024 | 609 | 0.470 |
Why?
|
| Spine | 6 | 2024 | 137 | 0.470 |
Why?
|
| Karyotyping | 22 | 2022 | 312 | 0.470 |
Why?
|
| DNA Helicases | 5 | 2023 | 229 | 0.470 |
Why?
|
| Chromosomes, Human, Y | 3 | 2011 | 48 | 0.470 |
Why?
|
| Primates | 5 | 2015 | 79 | 0.470 |
Why?
|
| Microfilament Proteins | 8 | 2018 | 269 | 0.470 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2015 | 7 | 0.460 |
Why?
|
| Microsatellite Repeats | 12 | 2019 | 229 | 0.460 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 90 | 0.460 |
Why?
|
| Fibroblasts | 9 | 2023 | 819 | 0.460 |
Why?
|
| Blotting, Southern | 15 | 2012 | 207 | 0.460 |
Why?
|
| Signal Transduction | 12 | 2025 | 4472 | 0.460 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2024 | 208 | 0.450 |
Why?
|
| Cloning, Molecular | 20 | 2013 | 784 | 0.450 |
Why?
|
| Neurofibromatosis 1 | 2 | 2012 | 65 | 0.450 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 4 | 2022 | 36 | 0.450 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 2017 | 104 | 0.450 |
Why?
|
| DEAD-box RNA Helicases | 4 | 2023 | 160 | 0.450 |
Why?
|
| Gain of Function Mutation | 3 | 2022 | 99 | 0.450 |
Why?
|
| Intestinal Pseudo-Obstruction | 4 | 2019 | 30 | 0.450 |
Why?
|
| Hypopituitarism | 1 | 2015 | 18 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 15 | 8 | 2017 | 143 | 0.450 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 146 | 0.440 |
Why?
|
| Pituitary Gland | 1 | 2015 | 77 | 0.440 |
Why?
|
| Neural Conduction | 18 | 2018 | 78 | 0.440 |
Why?
|
| Psychotic Disorders | 4 | 2019 | 151 | 0.440 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 4 | 2023 | 422 | 0.440 |
Why?
|
| Blepharophimosis | 3 | 2021 | 25 | 0.440 |
Why?
|
| Operon | 11 | 1998 | 48 | 0.440 |
Why?
|
| DNA Primers | 17 | 2015 | 602 | 0.440 |
Why?
|
| RNA Splicing | 6 | 2026 | 230 | 0.430 |
Why?
|
| Gene Expression | 14 | 2019 | 1482 | 0.430 |
Why?
|
| Wolff-Parkinson-White Syndrome | 3 | 2024 | 73 | 0.430 |
Why?
|
| Introns | 9 | 2016 | 281 | 0.430 |
Why?
|
| Protein Folding | 3 | 2016 | 214 | 0.430 |
Why?
|
| Phosphotransferases | 1 | 2014 | 33 | 0.430 |
Why?
|
| Axons | 9 | 2022 | 373 | 0.430 |
Why?
|
| Bone Diseases, Developmental | 5 | 2017 | 60 | 0.420 |
Why?
|
| Myelin Sheath | 4 | 2010 | 119 | 0.420 |
Why?
|
| Cell Polarity | 4 | 2024 | 116 | 0.420 |
Why?
|
| HEK293 Cells | 13 | 2025 | 767 | 0.420 |
Why?
|
| Bacteria | 7 | 2002 | 502 | 0.420 |
Why?
|
| Oxidoreductases | 5 | 2023 | 99 | 0.420 |
Why?
|
| Refsum Disease | 1 | 2013 | 4 | 0.420 |
Why?
|
| Autism Spectrum Disorder | 4 | 2023 | 423 | 0.420 |
Why?
|
| Peripheral Nerves | 8 | 2009 | 81 | 0.420 |
Why?
|
| RNA, Transfer | 1 | 2014 | 68 | 0.420 |
Why?
|
| Receptors, Immunologic | 3 | 2022 | 118 | 0.420 |
Why?
|
| Middle Aged | 45 | 2025 | 27697 | 0.420 |
Why?
|
| Central Nervous System | 4 | 2025 | 272 | 0.410 |
Why?
|
| Brain Diseases | 4 | 2022 | 283 | 0.410 |
Why?
|
| Micrognathism | 3 | 2021 | 65 | 0.410 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 94 | 0.410 |
Why?
|
| Mullerian Ducts | 3 | 2023 | 46 | 0.410 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 4 | 2006 | 39 | 0.410 |
Why?
|
| Chromatin | 5 | 2024 | 472 | 0.410 |
Why?
|
| Chronobiology Disorders | 1 | 2013 | 8 | 0.400 |
Why?
|
| Retinal Rod Photoreceptor Cells | 3 | 2018 | 86 | 0.400 |
Why?
|
| Centromere | 5 | 2005 | 67 | 0.400 |
Why?
|
| Alkyl and Aryl Transferases | 3 | 1997 | 17 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 5 | 6 | 2021 | 108 | 0.400 |
Why?
|
| Bacterial Proteins | 12 | 2007 | 912 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 10 | 3 | 2012 | 65 | 0.400 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2012 | 2 | 0.390 |
Why?
|
| Vesico-Ureteral Reflux | 4 | 2022 | 81 | 0.390 |
Why?
|
| Vesicular Transport Proteins | 4 | 2024 | 137 | 0.390 |
Why?
|
| Paralysis | 3 | 2010 | 30 | 0.390 |
Why?
|
| Face | 8 | 2020 | 193 | 0.390 |
Why?
|
| Mice, Knockout | 16 | 2023 | 3709 | 0.390 |
Why?
|
| Neurodegenerative Diseases | 4 | 2022 | 272 | 0.390 |
Why?
|
| Chromosomes, Artificial, Bacterial | 5 | 2008 | 90 | 0.380 |
Why?
|
| Genes | 11 | 2020 | 304 | 0.380 |
Why?
|
| Bone and Bones | 5 | 2019 | 294 | 0.380 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 2 | 2010 | 17 | 0.380 |
Why?
|
| Biological Evolution | 5 | 2021 | 222 | 0.380 |
Why?
|
| DNA End-Joining Repair | 4 | 2020 | 38 | 0.380 |
Why?
|
| Neurons | 7 | 2022 | 1919 | 0.380 |
Why?
|
| Sequence Homology | 3 | 2020 | 59 | 0.380 |
Why?
|
| Neurofibromin 1 | 1 | 2012 | 49 | 0.370 |
Why?
|
| Autophagy | 4 | 2021 | 404 | 0.370 |
Why?
|
| Protein Structure, Tertiary | 8 | 2014 | 718 | 0.370 |
Why?
|
| Chromosome Segregation | 5 | 2025 | 70 | 0.370 |
Why?
|
| Behavior, Animal | 4 | 2012 | 494 | 0.370 |
Why?
|
| Musculoskeletal Abnormalities | 3 | 2022 | 63 | 0.370 |
Why?
|
| Gene Order | 6 | 2014 | 78 | 0.370 |
Why?
|
| Cation Transport Proteins | 3 | 2022 | 99 | 0.370 |
Why?
|
| Polymorphism, Restriction Fragment Length | 11 | 1995 | 138 | 0.370 |
Why?
|
| Genetics, Population | 3 | 2011 | 184 | 0.360 |
Why?
|
| Chromosome Pairing | 1 | 2011 | 7 | 0.360 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 2 | 2022 | 12 | 0.360 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2001 | 21 | 0.360 |
Why?
|
| Golgi Apparatus | 3 | 2025 | 90 | 0.360 |
Why?
|
| Microarray Analysis | 6 | 2019 | 224 | 0.360 |
Why?
|
| History, 20th Century | 4 | 2019 | 369 | 0.360 |
Why?
|
| Phosphoric Diester Hydrolases | 4 | 2013 | 67 | 0.360 |
Why?
|
| GTP-Binding Proteins | 4 | 2021 | 160 | 0.360 |
Why?
|
| Obesity | 7 | 2024 | 2332 | 0.360 |
Why?
|
| DNA Methylation | 6 | 2025 | 1025 | 0.360 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 380 | 0.360 |
Why?
|
| Lissencephaly | 2 | 2022 | 10 | 0.350 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2021 | 579 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2024 | 3695 | 0.350 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2024 | 234 | 0.350 |
Why?
|
| Alternative Splicing | 7 | 2026 | 296 | 0.350 |
Why?
|
| Gametogenesis | 3 | 2017 | 26 | 0.350 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 81 | 0.350 |
Why?
|
| Sural Nerve | 13 | 2006 | 43 | 0.350 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2023 | 39 | 0.350 |
Why?
|
| Zinc Fingers | 8 | 2025 | 107 | 0.350 |
Why?
|
| Dystonia | 2 | 2023 | 162 | 0.350 |
Why?
|
| Transposases | 5 | 2019 | 40 | 0.340 |
Why?
|
| Optic Atrophy | 3 | 2016 | 46 | 0.340 |
Why?
|
| Agammaglobulinemia | 2 | 2021 | 43 | 0.340 |
Why?
|
| RNA Helicases | 3 | 2019 | 75 | 0.340 |
Why?
|
| X Chromosome Inactivation | 6 | 2019 | 60 | 0.340 |
Why?
|
| Cells, Cultured | 16 | 2019 | 2893 | 0.340 |
Why?
|
| Cerebellum | 6 | 2023 | 414 | 0.330 |
Why?
|
| Muscle, Skeletal | 6 | 2021 | 972 | 0.330 |
Why?
|
| Minichromosome Maintenance Proteins | 2 | 2020 | 11 | 0.330 |
Why?
|
| Phosphoric Monoester Hydrolases | 4 | 2021 | 96 | 0.320 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 293 | 0.320 |
Why?
|
| Photoreceptor Cells | 4 | 2007 | 91 | 0.320 |
Why?
|
| Whole Genome Sequencing | 7 | 2021 | 319 | 0.320 |
Why?
|
| Williams Syndrome | 6 | 2013 | 41 | 0.320 |
Why?
|
| Klebsiella Infections | 2 | 2004 | 61 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 14 | 2020 | 4504 | 0.320 |
Why?
|
| Protein Conformation | 10 | 2021 | 800 | 0.320 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2020 | 260 | 0.310 |
Why?
|
| Antigens, Neoplasm | 3 | 2021 | 398 | 0.310 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2024 | 92 | 0.310 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2016 | 321 | 0.310 |
Why?
|
| Cataract | 2 | 2023 | 142 | 0.310 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2021 | 217 | 0.310 |
Why?
|
| Muscular Dystrophies | 3 | 2023 | 52 | 0.310 |
Why?
|
| Drosophila | 9 | 2024 | 767 | 0.300 |
Why?
|
| Hedgehog Proteins | 3 | 2022 | 197 | 0.300 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2009 | 19 | 0.300 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 6 | 2008 | 92 | 0.300 |
Why?
|
| 3' Untranslated Regions | 3 | 2012 | 154 | 0.300 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2018 | 152 | 0.300 |
Why?
|
| Truth Disclosure | 1 | 2010 | 106 | 0.300 |
Why?
|
| Gelsolin | 3 | 2002 | 13 | 0.290 |
Why?
|
| Germ Cells | 5 | 2022 | 197 | 0.290 |
Why?
|
| Eye Proteins | 5 | 2018 | 229 | 0.290 |
Why?
|
| Mutagenesis, Insertional | 5 | 2015 | 149 | 0.290 |
Why?
|
| Mitochondrial Diseases | 2 | 2021 | 145 | 0.290 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 3 | 2022 | 14 | 0.290 |
Why?
|
| Fetus | 4 | 2014 | 578 | 0.290 |
Why?
|
| N-Terminal Acetyltransferase A | 2 | 2018 | 10 | 0.290 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2000 | 111 | 0.290 |
Why?
|
| N-Terminal Acetyltransferase E | 2 | 2018 | 11 | 0.290 |
Why?
|
| Chromosomes, Bacterial | 6 | 1997 | 65 | 0.290 |
Why?
|
| Chromosome Banding | 13 | 2012 | 136 | 0.280 |
Why?
|
| DNA, Complementary | 9 | 2005 | 434 | 0.280 |
Why?
|
| Loss of Heterozygosity | 2 | 2021 | 122 | 0.280 |
Why?
|
| Lymphopenia | 2 | 2021 | 33 | 0.280 |
Why?
|
| Metalloendopeptidases | 3 | 2017 | 99 | 0.280 |
Why?
|
| Forkhead Transcription Factors | 5 | 2023 | 360 | 0.280 |
Why?
|
| RNA Splice Sites | 4 | 2020 | 88 | 0.280 |
Why?
|
| Multiprotein Complexes | 6 | 2016 | 191 | 0.280 |
Why?
|
| Ribosomal Proteins | 5 | 2018 | 71 | 0.280 |
Why?
|
| Thymidine Phosphorylase | 2 | 2004 | 12 | 0.280 |
Why?
|
| Suppression, Genetic | 3 | 2015 | 41 | 0.280 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 154 | 0.280 |
Why?
|
| Urinary Bladder | 4 | 2019 | 247 | 0.270 |
Why?
|
| Fibrillar Collagens | 2 | 2020 | 14 | 0.270 |
Why?
|
| DNA Breaks | 3 | 2013 | 25 | 0.270 |
Why?
|
| Cosmids | 6 | 2001 | 40 | 0.270 |
Why?
|
| Locomotion | 2 | 2025 | 59 | 0.270 |
Why?
|
| Infertility, Male | 1 | 2011 | 287 | 0.270 |
Why?
|
| Schwann Cells | 2 | 2007 | 56 | 0.270 |
Why?
|
| Genetic Engineering | 2 | 2007 | 159 | 0.270 |
Why?
|
| Dystonic Disorders | 2 | 2023 | 95 | 0.270 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2023 | 75 | 0.260 |
Why?
|
| Color Vision Defects | 1 | 2007 | 4 | 0.260 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 3 | 2017 | 54 | 0.260 |
Why?
|
| Psychomotor Performance | 2 | 2011 | 172 | 0.260 |
Why?
|
| Binding Sites | 7 | 2025 | 1185 | 0.260 |
Why?
|
| Chromosomes, Artificial, P1 Bacteriophage | 2 | 2004 | 6 | 0.260 |
Why?
|
| Apoptosis | 5 | 2022 | 1811 | 0.260 |
Why?
|
| Codon, Terminator | 2 | 2023 | 26 | 0.260 |
Why?
|
| Acromegaly | 3 | 2016 | 10 | 0.260 |
Why?
|
| Restriction Mapping | 8 | 2003 | 173 | 0.260 |
Why?
|
| Synteny | 3 | 2006 | 69 | 0.260 |
Why?
|
| Neural Stem Cells | 3 | 2024 | 130 | 0.260 |
Why?
|
| Protein Isoforms | 6 | 2023 | 404 | 0.260 |
Why?
|
| Expressed Sequence Tags | 6 | 2002 | 78 | 0.260 |
Why?
|
| Models, Molecular | 8 | 2021 | 1057 | 0.260 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2019 | 154 | 0.260 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2016 | 76 | 0.250 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 41 | 0.250 |
Why?
|
| Dishevelled Proteins | 4 | 2020 | 43 | 0.250 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2023 | 415 | 0.250 |
Why?
|
| Plasmids | 11 | 2001 | 445 | 0.250 |
Why?
|
| Wnt Proteins | 5 | 2021 | 200 | 0.250 |
Why?
|
| DNA Primase | 12 | 1997 | 21 | 0.250 |
Why?
|
| Melatonin | 2 | 2011 | 28 | 0.250 |
Why?
|
| Interphase | 4 | 2005 | 35 | 0.250 |
Why?
|
| HeLa Cells | 5 | 2023 | 684 | 0.250 |
Why?
|
| Aged | 27 | 2025 | 20344 | 0.250 |
Why?
|
| Muscular Diseases | 3 | 2023 | 116 | 0.250 |
Why?
|
| Endoplasmic Reticulum | 2 | 2015 | 202 | 0.250 |
Why?
|
| Mediator Complex | 3 | 2023 | 55 | 0.240 |
Why?
|
| Communicable Diseases | 2 | 2002 | 153 | 0.240 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2025 | 258 | 0.240 |
Why?
|
| Threonine | 1 | 2006 | 60 | 0.240 |
Why?
|
| Osteochondrodysplasias | 3 | 2014 | 66 | 0.240 |
Why?
|
| Wnt Signaling Pathway | 4 | 2024 | 198 | 0.240 |
Why?
|
| Urinary Tract | 2 | 2022 | 61 | 0.240 |
Why?
|
| RNA Splicing Factors | 1 | 2026 | 52 | 0.240 |
Why?
|
| Receptor, EphA4 | 1 | 2025 | 5 | 0.240 |
Why?
|
| Body Height | 2 | 2021 | 191 | 0.240 |
Why?
|
| CRISPR-Cas Systems | 4 | 2025 | 277 | 0.240 |
Why?
|
| Marfan Syndrome | 2 | 2019 | 144 | 0.240 |
Why?
|
| Cytogenetic Analysis | 5 | 2012 | 79 | 0.230 |
Why?
|
| Methionine | 1 | 2006 | 90 | 0.230 |
Why?
|
| RNA Interference | 2 | 2019 | 492 | 0.230 |
Why?
|
| Cleft Palate | 2 | 2021 | 214 | 0.230 |
Why?
|
| Muscle Weakness | 3 | 2016 | 86 | 0.230 |
Why?
|
| Ion Channels | 1 | 2007 | 201 | 0.230 |
Why?
|
| Twins, Monozygotic | 3 | 2017 | 124 | 0.230 |
Why?
|
| Phosphorylation | 5 | 2021 | 1536 | 0.230 |
Why?
|
| Mammals | 2 | 2023 | 247 | 0.230 |
Why?
|
| Tandem Repeat Sequences | 4 | 2007 | 35 | 0.230 |
Why?
|
| Cell Cycle | 5 | 2019 | 585 | 0.230 |
Why?
|
| Colon | 3 | 2019 | 353 | 0.230 |
Why?
|
| Protein Phosphatase 1 | 3 | 2024 | 52 | 0.230 |
Why?
|
| Transcription Factor AP-2 | 1 | 2025 | 21 | 0.230 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2025 | 10 | 0.230 |
Why?
|
| Spliceosomes | 1 | 2025 | 47 | 0.230 |
Why?
|
| Physical Chromosome Mapping | 6 | 2007 | 52 | 0.230 |
Why?
|
| Spindle Apparatus | 1 | 2025 | 46 | 0.230 |
Why?
|
| Family Health | 8 | 2014 | 248 | 0.220 |
Why?
|
| Membrane Glycoproteins | 3 | 2024 | 416 | 0.220 |
Why?
|
| Genotyping Techniques | 2 | 2016 | 108 | 0.220 |
Why?
|
| Xenopus | 1 | 2005 | 103 | 0.220 |
Why?
|
| Microphthalmos | 2 | 2023 | 53 | 0.220 |
Why?
|
| Histidine | 3 | 2022 | 73 | 0.220 |
Why?
|
| Capillary Permeability | 1 | 2004 | 70 | 0.220 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2020 | 523 | 0.220 |
Why?
|
| Cytoplasmic Granules | 1 | 2025 | 50 | 0.220 |
Why?
|
| Citrobacter | 2 | 1995 | 20 | 0.220 |
Why?
|
| Myosins | 4 | 2011 | 41 | 0.220 |
Why?
|
| Tubulin | 3 | 2022 | 67 | 0.220 |
Why?
|
| Essential Hypertension | 1 | 2024 | 12 | 0.220 |
Why?
|
| Spinocerebellar Ataxias | 3 | 2005 | 250 | 0.220 |
Why?
|
| Homeodomain Proteins | 6 | 2021 | 538 | 0.220 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2012 | 270 | 0.220 |
Why?
|
| Methyltransferases | 1 | 2025 | 79 | 0.220 |
Why?
|
| Kidney | 6 | 2022 | 1283 | 0.210 |
Why?
|
| Contracture | 2 | 2022 | 27 | 0.210 |
Why?
|
| Neurofilament Proteins | 2 | 2003 | 29 | 0.210 |
Why?
|
| Neoplasms | 8 | 2019 | 2855 | 0.210 |
Why?
|
| Tissue Distribution | 6 | 2004 | 362 | 0.210 |
Why?
|
| Eye Diseases, Hereditary | 2 | 2017 | 27 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2020 | 477 | 0.210 |
Why?
|
| Neutropenia | 2 | 2022 | 198 | 0.210 |
Why?
|
| DNA Damage | 6 | 2020 | 498 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2004 | 140 | 0.210 |
Why?
|
| Hyperparathyroidism | 1 | 2024 | 26 | 0.210 |
Why?
|
| Circadian Rhythm | 2 | 2011 | 306 | 0.210 |
Why?
|
| Skin | 5 | 2019 | 516 | 0.210 |
Why?
|
| Lipodystrophy | 2 | 2019 | 32 | 0.210 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2001 | 333 | 0.210 |
Why?
|
| Electrophysiology | 7 | 2006 | 252 | 0.210 |
Why?
|
| Isochromosomes | 3 | 2012 | 17 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2021 | 968 | 0.210 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 14 | 0.200 |
Why?
|
| Hypogonadism | 3 | 2019 | 318 | 0.200 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 48 | 0.200 |
Why?
|
| Phylogeny | 4 | 2007 | 686 | 0.200 |
Why?
|
| Phospholipase C gamma | 1 | 2023 | 28 | 0.200 |
Why?
|
| Reproducibility of Results | 10 | 2017 | 2883 | 0.200 |
Why?
|
| Paraparesis, Spastic | 1 | 2023 | 4 | 0.200 |
Why?
|
| Behavioral Symptoms | 1 | 2003 | 25 | 0.200 |
Why?
|
| Goldenhar Syndrome | 1 | 2023 | 15 | 0.200 |
Why?
|
| Gene Amplification | 3 | 2015 | 227 | 0.200 |
Why?
|
| Biological Variation, Population | 2 | 2024 | 26 | 0.200 |
Why?
|
| Neisseria meningitidis | 3 | 2005 | 20 | 0.200 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2024 | 108 | 0.200 |
Why?
|
| Protein Biosynthesis | 7 | 2007 | 565 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2003 | 26 | 0.200 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2002 | 8 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2022 | 350 | 0.200 |
Why?
|
| Polydactyly | 2 | 2022 | 18 | 0.200 |
Why?
|
| Fanconi Anemia | 1 | 2023 | 40 | 0.200 |
Why?
|
| GPI-Linked Proteins | 2 | 2021 | 104 | 0.190 |
Why?
|
| Iran | 1 | 2023 | 96 | 0.190 |
Why?
|
| Templates, Genetic | 4 | 2013 | 55 | 0.190 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 12 | 0.190 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.190 |
Why?
|
| 14-3-3 Proteins | 2 | 2015 | 56 | 0.190 |
Why?
|
| DNA Probes | 6 | 2008 | 118 | 0.190 |
Why?
|
| Oncogene Proteins | 2 | 2018 | 133 | 0.190 |
Why?
|
| Chaperonins | 1 | 2002 | 15 | 0.190 |
Why?
|
| Methicillin Resistance | 3 | 2005 | 116 | 0.190 |
Why?
|
| Hominidae | 2 | 2007 | 25 | 0.190 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2022 | 10 | 0.190 |
Why?
|
| Databases, Nucleic Acid | 1 | 2002 | 72 | 0.190 |
Why?
|
| Proton-Translocating ATPases | 1 | 2002 | 18 | 0.190 |
Why?
|
| Apyrase | 1 | 2022 | 20 | 0.190 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2015 | 30 | 0.190 |
Why?
|
| Osteoporosis | 1 | 2023 | 132 | 0.190 |
Why?
|
| Angelman Syndrome | 1 | 2022 | 66 | 0.190 |
Why?
|
| Endoplasmic Reticulum Stress | 4 | 2018 | 122 | 0.190 |
Why?
|
| Fibrillin-1 | 2 | 2019 | 59 | 0.190 |
Why?
|
| Muscles | 5 | 2016 | 222 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2025 | 478 | 0.180 |
Why?
|
| Saudi Arabia | 7 | 2011 | 41 | 0.180 |
Why?
|
| Egypt | 1 | 2021 | 27 | 0.180 |
Why?
|
| Nitrogen | 1 | 2022 | 122 | 0.180 |
Why?
|
| Tangier Disease | 1 | 2001 | 5 | 0.180 |
Why?
|
| Protein Kinases | 1 | 2003 | 318 | 0.180 |
Why?
|
| Blotting, Northern | 5 | 2004 | 235 | 0.180 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2020 | 161 | 0.180 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2004 | 33 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 3 | 2021 | 613 | 0.180 |
Why?
|
| Disease Outbreaks | 4 | 2002 | 307 | 0.180 |
Why?
|
| Calpain | 1 | 2021 | 41 | 0.180 |
Why?
|
| Night Blindness | 1 | 2001 | 3 | 0.180 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 13 | 0.180 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 277 | 0.180 |
Why?
|
| Retrospective Studies | 15 | 2024 | 17005 | 0.180 |
Why?
|
| Gene-Environment Interaction | 2 | 2012 | 126 | 0.180 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 336 | 0.180 |
Why?
|
| Chloroquine | 1 | 2001 | 30 | 0.180 |
Why?
|
| Myelin P2 Protein | 2 | 2018 | 10 | 0.180 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 9 | 0.180 |
Why?
|
| Hydroxychloroquine | 1 | 2001 | 19 | 0.180 |
Why?
|
| Aminoquinolines | 1 | 2001 | 35 | 0.180 |
Why?
|
| Lipoproteins | 1 | 2002 | 183 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 2 | 2021 | 216 | 0.170 |
Why?
|
| RGS Proteins | 1 | 2021 | 47 | 0.170 |
Why?
|
| Solute Carrier Proteins | 1 | 2021 | 4 | 0.170 |
Why?
|
| Muscle Proteins | 2 | 2021 | 398 | 0.170 |
Why?
|
| Heterotaxy Syndrome | 2 | 2019 | 53 | 0.170 |
Why?
|
| Wolffian Ducts | 1 | 2021 | 10 | 0.170 |
Why?
|
| Immunologic Memory | 2 | 2020 | 194 | 0.170 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2021 | 6 | 0.170 |
Why?
|
| Mice, Mutant Strains | 5 | 2013 | 365 | 0.170 |
Why?
|
| Genetic Techniques | 4 | 2006 | 99 | 0.170 |
Why?
|
| Cricetinae | 8 | 2015 | 365 | 0.170 |
Why?
|
| Sex Chromosomes | 2 | 2012 | 30 | 0.170 |
Why?
|
| Prader-Willi Syndrome | 2 | 2017 | 62 | 0.170 |
Why?
|
| Pregnancy | 15 | 2018 | 7373 | 0.170 |
Why?
|
| Glutamine | 1 | 2022 | 196 | 0.170 |
Why?
|
| Myopia | 2 | 2021 | 106 | 0.170 |
Why?
|
| Iron Metabolism Disorders | 1 | 2020 | 13 | 0.170 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2020 | 16 | 0.170 |
Why?
|
| Pituitary Neoplasms | 3 | 2016 | 77 | 0.170 |
Why?
|
| Mitochondrial Membranes | 1 | 2020 | 32 | 0.170 |
Why?
|
| Enterobacteriaceae Infections | 3 | 1996 | 57 | 0.170 |
Why?
|
| Transferases | 2 | 1997 | 4 | 0.170 |
Why?
|
| Genes, Suppressor | 2 | 1997 | 12 | 0.170 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 19 | 0.170 |
Why?
|
| Dwarfism, Pituitary | 1 | 2020 | 6 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2016 | 32 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 30 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 42 | 0.160 |
Why?
|
| Evidence-Based Medicine | 7 | 2009 | 613 | 0.160 |
Why?
|
| Muscular Atrophy | 2 | 2014 | 74 | 0.160 |
Why?
|
| Renal Insufficiency | 2 | 2022 | 249 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2010 | 138 | 0.160 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2020 | 30 | 0.160 |
Why?
|
| Arginine | 3 | 2019 | 335 | 0.160 |
Why?
|
| Cadherins | 2 | 2018 | 174 | 0.160 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 48 | 0.160 |
Why?
|
| Aneuploidy | 4 | 2014 | 139 | 0.160 |
Why?
|
| Progeria | 1 | 2019 | 16 | 0.160 |
Why?
|
| Encephalitis | 1 | 2021 | 117 | 0.160 |
Why?
|
| Glycine-tRNA Ligase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Alzheimer Disease | 3 | 2012 | 835 | 0.160 |
Why?
|
| Netrins | 1 | 2019 | 5 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 149 | 0.160 |
Why?
|
| Asymmetric Cell Division | 1 | 2019 | 8 | 0.160 |
Why?
|
| GTP-Binding Protein beta Subunits | 2 | 2017 | 33 | 0.160 |
Why?
|
| Adenoma | 3 | 2016 | 143 | 0.160 |
Why?
|
| Deafness | 4 | 2020 | 81 | 0.160 |
Why?
|
| Uterus | 2 | 2023 | 532 | 0.160 |
Why?
|
| Ribosomes | 1 | 2020 | 123 | 0.160 |
Why?
|
| Primed In Situ Labeling | 1 | 1999 | 1 | 0.160 |
Why?
|
| Endoribonucleases | 3 | 2022 | 84 | 0.160 |
Why?
|
| Information Dissemination | 1 | 2022 | 189 | 0.160 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 2 | 2017 | 13 | 0.160 |
Why?
|
| Ataxia | 2 | 2022 | 160 | 0.160 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2019 | 32 | 0.160 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2020 | 316 | 0.160 |
Why?
|
| Radiography | 6 | 2019 | 752 | 0.160 |
Why?
|
| Hip Dislocation | 1 | 2020 | 36 | 0.160 |
Why?
|
| White Matter | 1 | 2022 | 205 | 0.160 |
Why?
|
| Failure to Thrive | 4 | 2020 | 88 | 0.160 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2011 | 16 | 0.160 |
Why?
|
| Liver Failure | 1 | 2020 | 89 | 0.160 |
Why?
|
| Molecular Biology | 5 | 2006 | 68 | 0.160 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 1 | 1999 | 1 | 0.150 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2019 | 3 | 0.150 |
Why?
|
| Glycine Agents | 1 | 2019 | 10 | 0.150 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2019 | 8 | 0.150 |
Why?
|
| SOX9 Transcription Factor | 4 | 2007 | 86 | 0.150 |
Why?
|
| Peripheral Nervous System | 1 | 1999 | 44 | 0.150 |
Why?
|
| Metabolome | 1 | 2022 | 316 | 0.150 |
Why?
|
| Genetic Counseling | 4 | 2017 | 233 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2022 | 207 | 0.150 |
Why?
|
| Valine-tRNA Ligase | 1 | 2019 | 2 | 0.150 |
Why?
|
| Disease Management | 4 | 2021 | 541 | 0.150 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2019 | 11 | 0.150 |
Why?
|
| Organ Size | 3 | 2012 | 429 | 0.150 |
Why?
|
| Lipodystrophy, Congenital Generalized | 1 | 2018 | 5 | 0.150 |
Why?
|
| Staphylococcus aureus | 3 | 2005 | 470 | 0.150 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2019 | 20 | 0.150 |
Why?
|
| Linkage Disequilibrium | 1 | 2000 | 313 | 0.150 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 107 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2019 | 156 | 0.150 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 225 | 0.150 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2021 | 167 | 0.150 |
Why?
|
| Sensitivity and Specificity | 9 | 2013 | 2065 | 0.150 |
Why?
|
| Embryonic Development | 2 | 2019 | 211 | 0.150 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 53 | 0.150 |
Why?
|
| Interspersed Repetitive Sequences | 3 | 2013 | 25 | 0.150 |
Why?
|
| Acyltransferases | 1 | 2018 | 62 | 0.150 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 270 | 0.150 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 81 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 169 | 0.150 |
Why?
|
| Sigma Factor | 4 | 1994 | 36 | 0.150 |
Why?
|
| Terminator Regions, Genetic | 3 | 1995 | 8 | 0.150 |
Why?
|
| Cleft Lip | 1 | 2021 | 187 | 0.150 |
Why?
|
| Plant Proteins | 1 | 1999 | 82 | 0.150 |
Why?
|
| Transcriptional Activation | 3 | 2007 | 412 | 0.140 |
Why?
|
| Species Specificity | 7 | 2010 | 514 | 0.140 |
Why?
|
| Risk | 3 | 2015 | 729 | 0.140 |
Why?
|
| RNA, Bacterial | 3 | 1989 | 53 | 0.140 |
Why?
|
| Sex Chromosome Aberrations | 2 | 2011 | 61 | 0.140 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2018 | 51 | 0.140 |
Why?
|
| Cell Movement | 4 | 2021 | 849 | 0.140 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2018 | 110 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 89 | 0.140 |
Why?
|
| Chromosomes, Artificial, Yeast | 5 | 1999 | 42 | 0.140 |
Why?
|
| Gene Expression Profiling | 4 | 2015 | 1753 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 33 | 0.140 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2018 | 33 | 0.140 |
Why?
|
| Protein Binding | 5 | 2025 | 1661 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 13 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 130 | 0.140 |
Why?
|
| Streptococcus pneumoniae | 3 | 1995 | 377 | 0.140 |
Why?
|
| Child Behavior | 2 | 2012 | 233 | 0.140 |
Why?
|
| Disorders of Sex Development | 3 | 2007 | 70 | 0.140 |
Why?
|
| Stem Cells | 4 | 2021 | 683 | 0.140 |
Why?
|
| Chloride Channels | 1 | 2018 | 60 | 0.140 |
Why?
|
| Cell Differentiation | 6 | 2021 | 1842 | 0.140 |
Why?
|
| Psychotropic Drugs | 1 | 2019 | 122 | 0.140 |
Why?
|
| Cholesterol | 2 | 2020 | 535 | 0.140 |
Why?
|
| Glycine | 1 | 2019 | 161 | 0.140 |
Why?
|
| DNA-Directed RNA Polymerases | 3 | 1994 | 75 | 0.140 |
Why?
|
| Sleep Wake Disorders | 2 | 2019 | 189 | 0.140 |
Why?
|
| Cilia | 4 | 2013 | 76 | 0.140 |
Why?
|
| beta Catenin | 1 | 2019 | 205 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 207 | 0.140 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2017 | 102 | 0.140 |
Why?
|
| Menopause, Premature | 2 | 2018 | 5 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 123 | 0.140 |
Why?
|
| Cross Infection | 3 | 1996 | 334 | 0.140 |
Why?
|
| Cell Line, Transformed | 5 | 2014 | 156 | 0.140 |
Why?
|
| Heart Ventricles | 3 | 2017 | 761 | 0.140 |
Why?
|
| Transcription Factor 4 | 1 | 2017 | 12 | 0.140 |
Why?
|
| Y Chromosome | 2 | 2002 | 45 | 0.130 |
Why?
|
| Hyperventilation | 1 | 2017 | 13 | 0.130 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 35 | 0.130 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2017 | 12 | 0.130 |
Why?
|
| Body Patterning | 2 | 2019 | 128 | 0.130 |
Why?
|
| 46, XX Testicular Disorders of Sex Development | 1 | 2017 | 2 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 2039 | 0.130 |
Why?
|
| Algorithms | 5 | 2018 | 1633 | 0.130 |
Why?
|
| Hybrid Cells | 8 | 1995 | 78 | 0.130 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2017 | 65 | 0.130 |
Why?
|
| Microscopy, Electron | 6 | 2007 | 307 | 0.130 |
Why?
|
| Mobius Syndrome | 1 | 2017 | 7 | 0.130 |
Why?
|
| COP9 Signalosome Complex | 3 | 2003 | 12 | 0.130 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.130 |
Why?
|
| Lod Score | 6 | 2015 | 127 | 0.130 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 42 | 0.130 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2016 | 13 | 0.130 |
Why?
|
| Liddle Syndrome | 1 | 2016 | 4 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 320 | 0.130 |
Why?
|
| Risperidone | 1 | 2017 | 61 | 0.130 |
Why?
|
| Meiosis | 3 | 2002 | 104 | 0.130 |
Why?
|
| Epidemiologic Methods | 2 | 1995 | 94 | 0.130 |
Why?
|
| Epithelial Sodium Channels | 1 | 2016 | 16 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 219 | 0.130 |
Why?
|
| Meningitis, Meningococcal | 1 | 1996 | 14 | 0.130 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2015 | 140 | 0.130 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2016 | 19 | 0.130 |
Why?
|
| Orthostatic Intolerance | 1 | 2016 | 6 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 43 | 0.130 |
Why?
|
| Genes, Reporter | 3 | 2019 | 345 | 0.130 |
Why?
|
| Hexokinase | 1 | 2016 | 25 | 0.130 |
Why?
|
| Octamer Transcription Factors | 1 | 2016 | 9 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 174 | 0.130 |
Why?
|
| Caveolin 3 | 1 | 2016 | 6 | 0.130 |
Why?
|
| Situs Inversus | 1 | 2016 | 25 | 0.130 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2016 | 19 | 0.130 |
Why?
|
| Myalgia | 1 | 2016 | 10 | 0.130 |
Why?
|
| Gene Editing | 1 | 2019 | 197 | 0.130 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 32 | 0.130 |
Why?
|
| Macula Lutea | 2 | 2015 | 25 | 0.130 |
Why?
|
| Muscle Spasticity | 3 | 2023 | 55 | 0.130 |
Why?
|
| Creatine Kinase | 1 | 2016 | 61 | 0.130 |
Why?
|
| Sinoatrial Node | 1 | 2016 | 24 | 0.130 |
Why?
|
| Immunohistochemistry | 5 | 2019 | 1597 | 0.120 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 257 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 330 | 0.120 |
Why?
|
| Memory | 2 | 2012 | 346 | 0.120 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2020 | 231 | 0.120 |
Why?
|
| Animals, Genetically Modified | 5 | 2018 | 325 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 734 | 0.120 |
Why?
|
| Keratoconus | 1 | 2016 | 44 | 0.120 |
Why?
|
| Bradycardia | 1 | 2016 | 55 | 0.120 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 177 | 0.120 |
Why?
|
| Feeding and Eating Disorders | 1 | 2017 | 73 | 0.120 |
Why?
|
| Retinal Degeneration | 2 | 2008 | 96 | 0.120 |
Why?
|
| Learning | 2 | 2012 | 357 | 0.120 |
Why?
|
| Gestational Age | 5 | 2020 | 1186 | 0.120 |
Why?
|
| Rats | 7 | 2022 | 3390 | 0.120 |
Why?
|
| Genetic Vectors | 6 | 2011 | 890 | 0.120 |
Why?
|
| Sirolimus | 1 | 2018 | 222 | 0.120 |
Why?
|
| Incidental Findings | 2 | 2014 | 121 | 0.120 |
Why?
|
| Peptide Hydrolases | 3 | 2003 | 131 | 0.120 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 22 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 330 | 0.120 |
Why?
|
| Privacy | 1 | 2016 | 27 | 0.120 |
Why?
|
| Geminin | 1 | 2015 | 7 | 0.120 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2020 | 396 | 0.120 |
Why?
|
| Data Mining | 1 | 2016 | 58 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2023 | 1018 | 0.120 |
Why?
|
| Tenascin | 1 | 2016 | 33 | 0.120 |
Why?
|
| Fertility | 1 | 2018 | 251 | 0.120 |
Why?
|
| Chorionic Villi Sampling | 3 | 2012 | 44 | 0.120 |
Why?
|
| Stem Cell Factor | 1 | 2015 | 11 | 0.120 |
Why?
|
| Plasmodium | 3 | 1984 | 10 | 0.120 |
Why?
|
| Functional Laterality | 1 | 2016 | 172 | 0.120 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2015 | 9 | 0.120 |
Why?
|
| Brain Edema | 1 | 2016 | 63 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2016 | 124 | 0.120 |
Why?
|
| Molecular Epidemiology | 4 | 2005 | 144 | 0.120 |
Why?
|
| Patella | 1 | 2015 | 27 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 445 | 0.120 |
Why?
|
| Genetic Load | 1 | 2015 | 5 | 0.120 |
Why?
|
| Amniocentesis | 3 | 2012 | 73 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 35 | 0.120 |
Why?
|
| Blindness, Cortical | 1 | 2015 | 15 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 217 | 0.120 |
Why?
|
| Adenosine Triphosphate | 3 | 2001 | 266 | 0.120 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2015 | 8 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 1222 | 0.120 |
Why?
|
| Caenorhabditis elegans | 4 | 2022 | 228 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2015 | 3 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2025 | 1705 | 0.120 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 500 | 0.120 |
Why?
|
| Factor XII Deficiency | 2 | 2005 | 2 | 0.120 |
Why?
|
| Spastin | 2 | 2014 | 8 | 0.120 |
Why?
|
| Fatal Outcome | 5 | 2020 | 358 | 0.120 |
Why?
|
| Mutation Rate | 2 | 2013 | 66 | 0.120 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2016 | 58 | 0.120 |
Why?
|
| Dosage Compensation, Genetic | 3 | 2002 | 57 | 0.120 |
Why?
|
| Prognosis | 8 | 2021 | 4772 | 0.120 |
Why?
|
| Antigens, Surface | 3 | 1987 | 114 | 0.120 |
Why?
|
| Endonucleases | 1 | 2015 | 48 | 0.120 |
Why?
|
| Cushing Syndrome | 1 | 2015 | 22 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 137 | 0.120 |
Why?
|
| Adrenal Glands | 1 | 2015 | 46 | 0.120 |
Why?
|
| Congenital Microtia | 1 | 2015 | 26 | 0.110 |
Why?
|
| Models, Theoretical | 2 | 2014 | 358 | 0.110 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 273 | 0.110 |
Why?
|
| Neonatal Screening | 1 | 2017 | 190 | 0.110 |
Why?
|
| Coatomer Protein | 1 | 2015 | 30 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2019 | 683 | 0.110 |
Why?
|
| China | 3 | 2021 | 277 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 968 | 0.110 |
Why?
|
| Xenopus laevis | 2 | 2005 | 118 | 0.110 |
Why?
|
| Exonucleases | 1 | 2015 | 27 | 0.110 |
Why?
|
| Gene Library | 5 | 2015 | 210 | 0.110 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 3 | 2011 | 89 | 0.110 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2016 | 84 | 0.110 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2014 | 25 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2019 | 395 | 0.110 |
Why?
|
| Chickenpox | 1 | 2014 | 21 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2017 | 1398 | 0.110 |
Why?
|
| Selection, Genetic | 2 | 2013 | 155 | 0.110 |
Why?
|
| Mutagens | 1 | 2015 | 48 | 0.110 |
Why?
|
| Rubella | 1 | 2014 | 18 | 0.110 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 77 | 0.110 |
Why?
|
| Duodenal Ulcer | 1 | 1995 | 126 | 0.110 |
Why?
|
| Ribonuclease III | 2 | 2014 | 101 | 0.110 |
Why?
|
| Oligonucleotides | 2 | 2013 | 94 | 0.110 |
Why?
|
| DNA, Recombinant | 5 | 1997 | 69 | 0.110 |
Why?
|
| Homocystinuria | 1 | 2015 | 26 | 0.110 |
Why?
|
| Genetic Carrier Screening | 2 | 1992 | 68 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 220 | 0.110 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 49 | 0.110 |
Why?
|
| Group II Chaperonins | 3 | 2005 | 5 | 0.110 |
Why?
|
| Azoospermia | 1 | 2015 | 48 | 0.110 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2014 | 7 | 0.110 |
Why?
|
| Antigens, CD | 2 | 2017 | 415 | 0.110 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 355 | 0.110 |
Why?
|
| Receptors, Lipoprotein | 1 | 2014 | 10 | 0.110 |
Why?
|
| Neurogenesis | 3 | 2024 | 206 | 0.110 |
Why?
|
| Molluscum Contagiosum | 1 | 2014 | 11 | 0.110 |
Why?
|
| Membrane Transport Proteins | 2 | 2023 | 176 | 0.110 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2015 | 44 | 0.110 |
Why?
|
| Phosphoglucomutase | 1 | 2014 | 7 | 0.110 |
Why?
|
| Hamartoma | 1 | 2015 | 49 | 0.110 |
Why?
|
| Embryo, Mammalian | 4 | 2016 | 443 | 0.110 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2014 | 13 | 0.110 |
Why?
|
| Otx Transcription Factors | 1 | 2014 | 25 | 0.110 |
Why?
|
| Arthritis | 1 | 2015 | 83 | 0.110 |
Why?
|
| Genes, Duplicate | 2 | 2007 | 16 | 0.110 |
Why?
|
| Pinealoma | 1 | 2014 | 19 | 0.110 |
Why?
|
| Cathepsin A | 1 | 2014 | 3 | 0.110 |
Why?
|
| Pineal Gland | 1 | 2014 | 21 | 0.110 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 27 | 0.110 |
Why?
|
| Nucleic Acid Heteroduplexes | 4 | 1996 | 17 | 0.110 |
Why?
|
| Lipomatosis | 1 | 2014 | 14 | 0.110 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 74 | 0.110 |
Why?
|
| Mucous Membrane | 1 | 2014 | 86 | 0.110 |
Why?
|
| Cytokines | 1 | 2020 | 1320 | 0.110 |
Why?
|
| Genome, Bacterial | 2 | 1992 | 205 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 359 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 113 | 0.110 |
Why?
|
| Sex Characteristics | 3 | 2014 | 311 | 0.110 |
Why?
|
| Anophthalmos | 1 | 2014 | 24 | 0.110 |
Why?
|
| Cerebrum | 1 | 2014 | 33 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2016 | 269 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 168 | 0.110 |
Why?
|
| Protein Structure, Secondary | 3 | 2023 | 237 | 0.110 |
Why?
|
| Granuloma | 1 | 2014 | 62 | 0.110 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 66 | 0.110 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2013 | 15 | 0.110 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2013 | 25 | 0.110 |
Why?
|
| Klebsiella pneumoniae | 1 | 1995 | 83 | 0.110 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2014 | 38 | 0.100 |
Why?
|
| Bone Marrow Diseases | 1 | 2014 | 41 | 0.100 |
Why?
|
| COUP Transcription Factor I | 1 | 2014 | 54 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 472 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 373 | 0.100 |
Why?
|
| Meningococcal Infections | 2 | 2005 | 20 | 0.100 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2013 | 35 | 0.100 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2014 | 37 | 0.100 |
Why?
|
| CHARGE Syndrome | 1 | 2013 | 8 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 2016 | 218 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2015 | 195 | 0.100 |
Why?
|
| Armadillo Domain Proteins | 1 | 2013 | 8 | 0.100 |
Why?
|
| Dyneins | 1 | 2013 | 12 | 0.100 |
Why?
|
| Death, Sudden | 1 | 2013 | 44 | 0.100 |
Why?
|
| Cytochrome P-450 CYP1B1 | 4 | 2006 | 30 | 0.100 |
Why?
|
| Mandatory Reporting | 1 | 2013 | 17 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 1351 | 0.100 |
Why?
|
| Kartagener Syndrome | 1 | 2013 | 13 | 0.100 |
Why?
|
| Informed Consent | 1 | 2016 | 337 | 0.100 |
Why?
|
| Electroretinography | 4 | 2015 | 105 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 30 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 32 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2007 | 75 | 0.100 |
Why?
|
| Mutant Proteins | 2 | 2018 | 111 | 0.100 |
Why?
|
| Haemophilus influenzae | 1 | 1993 | 135 | 0.100 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1995 | 249 | 0.100 |
Why?
|
| Running | 1 | 2013 | 32 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 1993 | 44 | 0.100 |
Why?
|
| Sciatic Nerve | 3 | 2013 | 47 | 0.100 |
Why?
|
| Electron Transport Complex IV | 3 | 1997 | 40 | 0.100 |
Why?
|
| Vision Disorders | 1 | 2015 | 188 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 174 | 0.100 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 114 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2011 | 55 | 0.100 |
Why?
|
| Histidine-tRNA Ligase | 1 | 2012 | 1 | 0.100 |
Why?
|
| Genes, Regulator | 3 | 2007 | 43 | 0.100 |
Why?
|
| Skin Abnormalities | 1 | 2013 | 35 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 1993 | 70 | 0.100 |
Why?
|
| Trinucleotide Repeats | 2 | 2018 | 101 | 0.100 |
Why?
|
| Yeasts | 2 | 2011 | 40 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2014 | 88 | 0.100 |
Why?
|
| Respiratory System | 1 | 2013 | 94 | 0.100 |
Why?
|
| Electroencephalography | 3 | 2024 | 821 | 0.100 |
Why?
|
| Sotos Syndrome | 1 | 2012 | 1 | 0.100 |
Why?
|
| Immune System | 1 | 2013 | 92 | 0.100 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 60 | 0.100 |
Why?
|
| Diagnosis, Differential | 5 | 2017 | 1861 | 0.100 |
Why?
|
| United States | 6 | 2024 | 11310 | 0.100 |
Why?
|
| Drinking | 1 | 2012 | 28 | 0.100 |
Why?
|
| Nerve Net | 1 | 2015 | 244 | 0.100 |
Why?
|
| Growth and Development | 1 | 2012 | 21 | 0.100 |
Why?
|
| Intelligence | 2 | 2010 | 91 | 0.100 |
Why?
|
| Colitis | 1 | 2014 | 156 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 269 | 0.100 |
Why?
|
| Glycogen | 2 | 2023 | 50 | 0.100 |
Why?
|
| Clone Cells | 3 | 2025 | 163 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 95 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 711 | 0.100 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 70 | 0.090 |
Why?
|
| Blindness | 3 | 2008 | 71 | 0.090 |
Why?
|
| Munc18 Proteins | 1 | 2012 | 20 | 0.090 |
Why?
|
| ras Proteins | 1 | 2013 | 140 | 0.090 |
Why?
|
| Contig Mapping | 2 | 2002 | 51 | 0.090 |
Why?
|
| Reference Values | 3 | 2021 | 683 | 0.090 |
Why?
|
| Nucleic Acid Conformation | 3 | 2007 | 169 | 0.090 |
Why?
|
| Child Rearing | 1 | 2012 | 26 | 0.090 |
Why?
|
| Lung | 2 | 2019 | 1516 | 0.090 |
Why?
|
| Leucine | 2 | 2007 | 258 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2013 | 284 | 0.090 |
Why?
|
| HapMap Project | 1 | 2012 | 13 | 0.090 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2009 | 42 | 0.090 |
Why?
|
| Transfer RNA Aminoacylation | 1 | 2011 | 1 | 0.090 |
Why?
|
| Alanine-tRNA Ligase | 1 | 2011 | 2 | 0.090 |
Why?
|
| Workflow | 3 | 2018 | 133 | 0.090 |
Why?
|
| Gastritis | 1 | 1995 | 371 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2007 | 1014 | 0.090 |
Why?
|
| Pseudogenes | 4 | 2007 | 50 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 476 | 0.090 |
Why?
|
| Inflammation | 4 | 2021 | 1420 | 0.090 |
Why?
|
| Human Genome Project | 1 | 2012 | 54 | 0.090 |
Why?
|
| Temperature | 5 | 2007 | 284 | 0.090 |
Why?
|
| Replication Protein A | 1 | 2011 | 10 | 0.090 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 27 | 0.090 |
Why?
|
| Monosomy | 1 | 1991 | 25 | 0.090 |
Why?
|
| Motor Neurons | 4 | 2015 | 122 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2012 | 80 | 0.090 |
Why?
|
| Sensory Receptor Cells | 2 | 2009 | 55 | 0.090 |
Why?
|
| Genetic Privacy | 1 | 2012 | 41 | 0.090 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2011 | 63 | 0.090 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2011 | 3 | 0.090 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 52 | 0.090 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 565 | 0.090 |
Why?
|
| Base Composition | 3 | 2013 | 71 | 0.090 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2022 | 78 | 0.090 |
Why?
|
| Societies, Medical | 2 | 2008 | 741 | 0.090 |
Why?
|
| Ganglioglioma | 1 | 2011 | 20 | 0.090 |
Why?
|
| Gene Targeting | 3 | 2012 | 167 | 0.090 |
Why?
|
| Ocular Motility Disorders | 2 | 2017 | 35 | 0.090 |
Why?
|
| Quadriplegia | 2 | 2022 | 35 | 0.090 |
Why?
|
| Seminal Plasma Proteins | 1 | 2011 | 7 | 0.090 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2011 | 15 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 1991 | 89 | 0.090 |
Why?
|
| Lymphocytes | 4 | 2012 | 354 | 0.090 |
Why?
|
| Biomedical Technology | 1 | 2011 | 34 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 3 | 1994 | 1204 | 0.090 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2010 | 5 | 0.080 |
Why?
|
| Aquaporins | 1 | 1990 | 16 | 0.080 |
Why?
|
| Open Reading Frames | 2 | 2001 | 201 | 0.080 |
Why?
|
| Europe | 3 | 2021 | 359 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2000 | 1193 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2022 | 172 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2012 | 708 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2012 | 175 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 4 | 1996 | 238 | 0.080 |
Why?
|
| Poland | 2 | 2007 | 55 | 0.080 |
Why?
|
| CpG Islands | 3 | 2013 | 329 | 0.080 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 96 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2012 | 207 | 0.080 |
Why?
|
| Cerebral Cortex | 3 | 2020 | 441 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1995 | 478 | 0.080 |
Why?
|
| Glycerol | 1 | 1990 | 80 | 0.080 |
Why?
|
| Microtubules | 3 | 2019 | 118 | 0.080 |
Why?
|
| Paternal Inheritance | 2 | 2021 | 10 | 0.080 |
Why?
|
| COS Cells | 2 | 2007 | 244 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2000 | 58 | 0.080 |
Why?
|
| Ethylnitrosourea | 1 | 2009 | 7 | 0.080 |
Why?
|
| Democratic Republic of the Congo | 2 | 2020 | 18 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1990 | 117 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2010 | 822 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 386 | 0.080 |
Why?
|
| Heterochromatin | 2 | 2007 | 46 | 0.080 |
Why?
|
| Bacteriophage lambda | 5 | 1991 | 24 | 0.080 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 1990 | 47 | 0.080 |
Why?
|
| Electrocardiography | 3 | 2024 | 967 | 0.080 |
Why?
|
| Pakistan | 2 | 2018 | 91 | 0.080 |
Why?
|
| Child Behavior Disorders | 1 | 2010 | 68 | 0.080 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 12 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2014 | 6668 | 0.080 |
Why?
|
| Antigens, Protozoan | 2 | 1987 | 80 | 0.080 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2009 | 4 | 0.080 |
Why?
|
| Vaccination | 1 | 2014 | 1004 | 0.080 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2020 | 155 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 217 | 0.070 |
Why?
|
| Cytogenetics | 2 | 2007 | 13 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 923 | 0.070 |
Why?
|
| Language | 2 | 2025 | 205 | 0.070 |
Why?
|
| Sister Chromatid Exchange | 1 | 2008 | 14 | 0.070 |
Why?
|
| LIM Domain Proteins | 2 | 2020 | 65 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2017 | 286 | 0.070 |
Why?
|
| Cytoskeleton | 2 | 2017 | 167 | 0.070 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 243 | 0.070 |
Why?
|
| Schizophrenia | 2 | 2008 | 320 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 1 | 2012 | 314 | 0.070 |
Why?
|
| Deglutition Disorders | 1 | 2010 | 138 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2017 | 646 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2012 | 313 | 0.070 |
Why?
|
| Time Factors | 5 | 2013 | 6134 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2007 | 1428 | 0.070 |
Why?
|
| Autonomic Nervous System | 1 | 2009 | 46 | 0.070 |
Why?
|
| Connectin | 2 | 2019 | 28 | 0.070 |
Why?
|
| Gorilla gorilla | 3 | 2007 | 12 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 5114 | 0.070 |
Why?
|
| Protein Transport | 3 | 2016 | 349 | 0.070 |
Why?
|
| Prevalence | 3 | 2021 | 2591 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2012 | 378 | 0.070 |
Why?
|
| Italy | 2 | 2021 | 133 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 87 | 0.070 |
Why?
|
| Internet | 1 | 2011 | 402 | 0.070 |
Why?
|
| Xenopus Proteins | 2 | 2005 | 59 | 0.070 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 2975 | 0.070 |
Why?
|
| Neural Crest | 1 | 2008 | 52 | 0.070 |
Why?
|
| Octamer Transcription Factor-6 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 2225 | 0.070 |
Why?
|
| Protein Domains | 2 | 2019 | 239 | 0.070 |
Why?
|
| SOXC Transcription Factors | 1 | 2007 | 9 | 0.070 |
Why?
|
| Corneal Opacity | 2 | 2020 | 19 | 0.070 |
Why?
|
| Flavoproteins | 1 | 2007 | 20 | 0.070 |
Why?
|
| Proteolysis | 2 | 2020 | 177 | 0.070 |
Why?
|
| Human Growth Hormone | 2 | 2020 | 75 | 0.070 |
Why?
|
| Sex Differentiation | 1 | 2007 | 16 | 0.070 |
Why?
|
| Sex Factors | 3 | 2019 | 1309 | 0.070 |
Why?
|
| Proline | 1 | 2007 | 76 | 0.070 |
Why?
|
| AT Rich Sequence | 1 | 2007 | 3 | 0.070 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2007 | 59 | 0.070 |
Why?
|
| Bacterial Toxins | 1 | 1988 | 171 | 0.070 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2007 | 34 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2018 | 330 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 79 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2010 | 64 | 0.070 |
Why?
|
| Echocardiography | 2 | 2021 | 1114 | 0.060 |
Why?
|
| Adipokines | 2 | 2019 | 116 | 0.060 |
Why?
|
| Flow Cytometry | 5 | 2014 | 754 | 0.060 |
Why?
|
| Aging | 2 | 2006 | 1193 | 0.060 |
Why?
|
| Chondrocytes | 1 | 2007 | 47 | 0.060 |
Why?
|
| Neurologic Examination | 3 | 2009 | 193 | 0.060 |
Why?
|
| Body Weight | 2 | 2012 | 970 | 0.060 |
Why?
|
| RecQ Helicases | 1 | 2007 | 62 | 0.060 |
Why?
|
| Cytidine Deaminase | 2 | 2020 | 31 | 0.060 |
Why?
|
| Karyotype | 2 | 2016 | 29 | 0.060 |
Why?
|
| Gene Conversion | 2 | 2006 | 14 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 228 | 0.060 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1997 | 69 | 0.060 |
Why?
|
| Reaction Time | 3 | 1996 | 156 | 0.060 |
Why?
|
| Social Dominance | 1 | 2006 | 11 | 0.060 |
Why?
|
| Tremor | 2 | 2024 | 130 | 0.060 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 19 | 0.060 |
Why?
|
| DNA Restriction Enzymes | 5 | 1995 | 73 | 0.060 |
Why?
|
| Hearing Loss | 1 | 2008 | 199 | 0.060 |
Why?
|
| Parents | 3 | 2020 | 1072 | 0.060 |
Why?
|
| Plasmodium falciparum | 1 | 1987 | 92 | 0.060 |
Why?
|
| Consensus Sequence | 3 | 1998 | 50 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2007 | 127 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 992 | 0.060 |
Why?
|
| Monophenol Monooxygenase | 1 | 2006 | 25 | 0.060 |
Why?
|
| Malaria | 1 | 1987 | 97 | 0.060 |
Why?
|
| Neuroimaging | 2 | 2021 | 359 | 0.060 |
Why?
|
| Intestine, Small | 1 | 1988 | 286 | 0.060 |
Why?
|
| Staphylococcal Infections | 2 | 2005 | 559 | 0.060 |
Why?
|
| Unfolded Protein Response | 2 | 2018 | 61 | 0.060 |
Why?
|
| Retinaldehyde | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 3498 | 0.060 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 109 | 0.060 |
Why?
|
| Helicobacter pylori | 1 | 1995 | 1324 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 290 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2016 | 167 | 0.060 |
Why?
|
| Base Pairing | 1 | 2005 | 40 | 0.060 |
Why?
|
| Helicobacter Infections | 1 | 1995 | 1266 | 0.060 |
Why?
|
| Protozoan Proteins | 1 | 1987 | 132 | 0.060 |
Why?
|
| Biological Ontologies | 1 | 2025 | 8 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1234 | 0.060 |
Why?
|
| Antibodies | 1 | 1987 | 351 | 0.060 |
Why?
|
| Amniotic Fluid | 3 | 2012 | 147 | 0.060 |
Why?
|
| Social Behavior | 1 | 2007 | 216 | 0.060 |
Why?
|
| Texas | 5 | 2017 | 3551 | 0.060 |
Why?
|
| Gastrulation | 2 | 2016 | 21 | 0.060 |
Why?
|
| Speech Disorders | 1 | 2005 | 47 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1224 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2004 | 16 | 0.060 |
Why?
|
| Microtubule-Organizing Center | 1 | 2025 | 6 | 0.060 |
Why?
|
| Glycolates | 1 | 2005 | 4 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2007 | 669 | 0.060 |
Why?
|
| Bacterial Infections | 2 | 2002 | 309 | 0.060 |
Why?
|
| Genetic Complementation Test | 2 | 2012 | 86 | 0.060 |
Why?
|
| Centrosome | 1 | 2025 | 24 | 0.060 |
Why?
|
| Mice, Neurologic Mutants | 3 | 1994 | 74 | 0.060 |
Why?
|
| Autopsy | 2 | 2016 | 112 | 0.060 |
Why?
|
| Primary Myelofibrosis | 1 | 2005 | 51 | 0.060 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2005 | 16 | 0.060 |
Why?
|
| Genes, X-Linked | 2 | 2016 | 60 | 0.060 |
Why?
|
| Leptin | 1 | 2006 | 218 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 307 | 0.060 |
Why?
|
| Automation | 1 | 2005 | 65 | 0.060 |
Why?
|
| DNA, Single-Stranded | 1 | 2005 | 69 | 0.060 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 77 | 0.050 |
Why?
|
| Olfaction Disorders | 1 | 2004 | 27 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2004 | 74 | 0.050 |
Why?
|
| Listeria monocytogenes | 2 | 1994 | 30 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2025 | 70 | 0.050 |
Why?
|
| Culture Media | 1 | 2005 | 169 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 2005 | 449 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2008 | 542 | 0.050 |
Why?
|
| Amino Acids | 2 | 2017 | 615 | 0.050 |
Why?
|
| Nail-Patella Syndrome | 1 | 2004 | 2 | 0.050 |
Why?
|
| Retroviridae | 1 | 2004 | 182 | 0.050 |
Why?
|
| R-SNARE Proteins | 1 | 2024 | 22 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 1293 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2024 | 44 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2005 | 815 | 0.050 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2005 | 71 | 0.050 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 8 | 0.050 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2004 | 14 | 0.050 |
Why?
|
| Chile | 1 | 2024 | 23 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 361 | 0.050 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2003 | 3 | 0.050 |
Why?
|
| Lamin Type A | 1 | 2003 | 11 | 0.050 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2023 | 16 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 1995 | 408 | 0.050 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2004 | 26 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1995 | 40 | 0.050 |
Why?
|
| Fetal Diseases | 2 | 2016 | 454 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 98 | 0.050 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2003 | 6 | 0.050 |
Why?
|
| Cations | 1 | 2023 | 37 | 0.050 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2003 | 7 | 0.050 |
Why?
|
| Chimera | 1 | 2003 | 80 | 0.050 |
Why?
|
| Genetics, Behavioral | 1 | 2003 | 8 | 0.050 |
Why?
|
| Blastocyst | 1 | 2003 | 75 | 0.050 |
Why?
|
| Glycosylation | 1 | 2023 | 111 | 0.050 |
Why?
|
| Dermis | 1 | 2003 | 23 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3662 | 0.050 |
Why?
|
| Melanocytes | 1 | 2003 | 44 | 0.050 |
Why?
|
| Cricetulus | 2 | 2015 | 87 | 0.050 |
Why?
|
| Sodium Bicarbonate | 1 | 2023 | 55 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 3 | 1996 | 192 | 0.050 |
Why?
|
| Mevalonic Acid | 1 | 2023 | 19 | 0.050 |
Why?
|
| Pigmentation Disorders | 1 | 2003 | 22 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 133 | 0.050 |
Why?
|
| CHO Cells | 2 | 2015 | 148 | 0.050 |
Why?
|
| Facial Asymmetry | 1 | 2023 | 17 | 0.050 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2023 | 32 | 0.050 |
Why?
|
| Retinoids | 1 | 2023 | 29 | 0.050 |
Why?
|
| Genes, Lethal | 2 | 2016 | 75 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2006 | 394 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 61 | 0.050 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2023 | 97 | 0.050 |
Why?
|
| Biopsy | 4 | 2009 | 1236 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2017 | 12546 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2003 | 24 | 0.050 |
Why?
|
| RNA, Small Nuclear | 1 | 2023 | 41 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2024 | 252 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 245 | 0.050 |
Why?
|
| Mice, Transgenic | 4 | 2012 | 2310 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2003 | 47 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 24 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 22 | 0.050 |
Why?
|
| Community-Acquired Infections | 1 | 2005 | 249 | 0.050 |
Why?
|
| Amines | 1 | 2022 | 37 | 0.050 |
Why?
|
| ADAMTS Proteins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 17 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 15 | 0.050 |
Why?
|
| Minority Groups | 1 | 2024 | 250 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2017 | 130 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 275 | 0.050 |
Why?
|
| Meningococcal Vaccines | 1 | 2002 | 30 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.050 |
Why?
|
| Trabecular Meshwork | 2 | 2002 | 11 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 89 | 0.050 |
Why?
|
| Guanosine | 1 | 2022 | 12 | 0.050 |
Why?
|
| NIH 3T3 Cells | 2 | 2015 | 92 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 24 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 2023 | 137 | 0.050 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2002 | 27 | 0.050 |
Why?
|
| Serotyping | 3 | 1998 | 171 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 130 | 0.050 |
Why?
|
| Vitamin B 12 | 2 | 2015 | 57 | 0.050 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2001 | 24 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2014 | 933 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 88 | 0.050 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2021 | 26 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2022 | 90 | 0.050 |
Why?
|
| Heteroduplex Analysis | 1 | 2001 | 4 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 111 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2022 | 52 | 0.050 |
Why?
|
| Behavior | 1 | 2002 | 69 | 0.050 |
Why?
|
| Fundus Oculi | 1 | 2001 | 30 | 0.050 |
Why?
|
| Zinc | 1 | 2022 | 121 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2002 | 122 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2014 | 3314 | 0.040 |
Why?
|
| Epitopes | 1 | 1983 | 418 | 0.040 |
Why?
|
| Dystrophin | 2 | 1991 | 41 | 0.040 |
Why?
|
| Risk Factors | 4 | 2014 | 10555 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 6214 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 356 | 0.040 |
Why?
|
| Lymphopoiesis | 1 | 2021 | 9 | 0.040 |
Why?
|
| Visual Acuity | 2 | 2015 | 485 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 400 | 0.040 |
Why?
|
| Insulin | 1 | 2006 | 1128 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2022 | 95 | 0.040 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 15 | 0.040 |
Why?
|
| Testis | 1 | 2003 | 405 | 0.040 |
Why?
|
| Chromosome Fragility | 1 | 2001 | 13 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2024 | 312 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 260 | 0.040 |
Why?
|
| Finland | 1 | 2021 | 46 | 0.040 |
Why?
|
| Insect Proteins | 2 | 2002 | 97 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2001 | 75 | 0.040 |
Why?
|
| Histones | 1 | 2025 | 502 | 0.040 |
Why?
|
| Iraq | 1 | 2001 | 11 | 0.040 |
Why?
|
| PAX8 Transcription Factor | 1 | 2021 | 14 | 0.040 |
Why?
|
| Talipes Cavus | 1 | 2020 | 2 | 0.040 |
Why?
|
| Receptors, Odorant | 2 | 2011 | 35 | 0.040 |
Why?
|
| Genetic Pleiotropy | 1 | 2021 | 25 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2021 | 25 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2021 | 36 | 0.040 |
Why?
|
| Amish | 1 | 2020 | 11 | 0.040 |
Why?
|
| Palate | 1 | 2020 | 19 | 0.040 |
Why?
|
| France | 2 | 2011 | 86 | 0.040 |
Why?
|
| Eye | 1 | 2002 | 218 | 0.040 |
Why?
|
| Vagina | 1 | 2022 | 200 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 56 | 0.040 |
Why?
|
| Atrioventricular Block | 1 | 2021 | 45 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2020 | 36 | 0.040 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2020 | 44 | 0.040 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 8 | 0.040 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2020 | 8 | 0.040 |
Why?
|
| Recurrence | 2 | 2014 | 1406 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 1995 | 2507 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1990 | 48 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 175 | 0.040 |
Why?
|
| Neuroglia | 1 | 2022 | 208 | 0.040 |
Why?
|
| Sleep, REM | 1 | 2000 | 15 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 58 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2397 | 0.040 |
Why?
|
| India | 1 | 2001 | 228 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 726 | 0.040 |
Why?
|
| Bone Development | 1 | 2020 | 54 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2021 | 665 | 0.040 |
Why?
|
| Rod Cell Outer Segment | 1 | 2000 | 45 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2024 | 381 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 230 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2019 | 51 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 2036 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 946 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 94 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 422 | 0.040 |
Why?
|
| Anxiety | 1 | 2006 | 964 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 198 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 224 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 372 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 33 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 207 | 0.040 |
Why?
|
| Genes, Plant | 1 | 1999 | 37 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 94 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 74 | 0.040 |
Why?
|
| Polysomnography | 1 | 2000 | 147 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 273 | 0.040 |
Why?
|
| Maternal Inheritance | 1 | 2019 | 14 | 0.040 |
Why?
|
| North America | 1 | 1999 | 249 | 0.040 |
Why?
|
| Electrodiagnosis | 2 | 2009 | 9 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2019 | 36 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 839 | 0.040 |
Why?
|
| Peroxidases | 1 | 2019 | 30 | 0.040 |
Why?
|
| Peroneal Nerve | 2 | 1996 | 3 | 0.040 |
Why?
|
| Median Nerve | 2 | 1996 | 13 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 38 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1999 | 93 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 223 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2002 | 381 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 232 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 180 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 130 | 0.040 |
Why?
|
| Visual Fields | 2 | 2015 | 132 | 0.040 |
Why?
|
| Liver | 1 | 2006 | 1765 | 0.040 |
Why?
|
| Salmonella enteritidis | 1 | 1998 | 5 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 132 | 0.040 |
Why?
|
| Amenorrhea | 1 | 2018 | 19 | 0.040 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2018 | 10 | 0.040 |
Why?
|
| Organogenesis | 1 | 2019 | 80 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 289 | 0.040 |
Why?
|
| Elastin | 1 | 1998 | 25 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2018 | 56 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 53 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 415 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 562 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2021 | 435 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 565 | 0.040 |
Why?
|
| Arabidopsis | 1 | 1999 | 89 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2009 | 199 | 0.030 |
Why?
|
| Zika Virus | 1 | 2019 | 151 | 0.030 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2018 | 73 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 3907 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1998 | 57 | 0.030 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2021 | 1207 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 230 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 2018 | 103 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 11 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2018 | 107 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2021 | 290 | 0.030 |
Why?
|
| Mothers | 2 | 2014 | 363 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2018 | 249 | 0.030 |
Why?
|
| Immunological Synapses | 1 | 2018 | 32 | 0.030 |
Why?
|
| Tropomyosin | 1 | 2017 | 26 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 79 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 38 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 412 | 0.030 |
Why?
|
| Ovarian Follicle | 1 | 2018 | 119 | 0.030 |
Why?
|
| Epithelium | 1 | 2018 | 336 | 0.030 |
Why?
|
| Heredity | 1 | 2017 | 15 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 326 | 0.030 |
Why?
|
| Calcium Channels, N-Type | 1 | 2017 | 47 | 0.030 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2017 | 11 | 0.030 |
Why?
|
| Matrix Attachment Regions | 1 | 2017 | 2 | 0.030 |
Why?
|
| Viremia | 1 | 2018 | 129 | 0.030 |
Why?
|
| Laminin | 1 | 2017 | 67 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 74 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 517 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2017 | 34 | 0.030 |
Why?
|
| Philadelphia Chromosome | 1 | 2017 | 42 | 0.030 |
Why?
|
| Ketoglutaric Acids | 1 | 2016 | 23 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 239 | 0.030 |
Why?
|
| Retroelements | 2 | 2007 | 39 | 0.030 |
Why?
|
| CD56 Antigen | 1 | 2016 | 26 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1997 | 81 | 0.030 |
Why?
|
| Amiloride | 1 | 2016 | 24 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2109 | 0.030 |
Why?
|
| Tilt-Table Test | 1 | 2016 | 9 | 0.030 |
Why?
|
| Oryzias | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 82 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 28 | 0.030 |
Why?
|
| Crystallography | 1 | 1996 | 38 | 0.030 |
Why?
|
| Renin | 1 | 2016 | 73 | 0.030 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2017 | 53 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 101 | 0.030 |
Why?
|
| Aldosterone | 1 | 2016 | 57 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 2017 | 50 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2019 | 192 | 0.030 |
Why?
|
| Hypokalemia | 1 | 2016 | 40 | 0.030 |
Why?
|
| Hydrochlorothiazide | 1 | 2016 | 62 | 0.030 |
Why?
|
| Biomarkers | 2 | 2003 | 3222 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 2016 | 19 | 0.030 |
Why?
|
| Enterobacter | 1 | 1996 | 12 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 19 | 0.030 |
Why?
|
| Audiometry | 1 | 1996 | 22 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 187 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 173 | 0.030 |
Why?
|
| Reflex, Stretch | 1 | 1996 | 1 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 2017 | 62 | 0.030 |
Why?
|
| Thigh | 1 | 2016 | 50 | 0.030 |
Why?
|
| Wnt-5a Protein | 1 | 2016 | 23 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2006 | 36 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 173 | 0.030 |
Why?
|
| Posture | 1 | 2016 | 132 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1997 | 191 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2020 | 1082 | 0.030 |
Why?
|
| Cysteine | 1 | 2016 | 137 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 2012 | 86 | 0.030 |
Why?
|
| Herpes Genitalis | 1 | 1995 | 10 | 0.030 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1137 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2015 | 20 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 148 | 0.030 |
Why?
|
| Factor XII | 2 | 2005 | 3 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 669 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 162 | 0.030 |
Why?
|
| Gene Components | 1 | 2015 | 8 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1584 | 0.030 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2015 | 5 | 0.030 |
Why?
|
| Fibrillins | 1 | 2015 | 28 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 46 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 1995 | 99 | 0.030 |
Why?
|
| Mutagenicity Tests | 1 | 2015 | 20 | 0.030 |
Why?
|
| Microscopy, Acoustic | 1 | 2015 | 13 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 2015 | 40 | 0.030 |
Why?
|
| Mycobacterium avium | 1 | 1995 | 16 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2015 | 85 | 0.030 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2014 | 5 | 0.030 |
Why?
|
| Legionella | 1 | 1994 | 9 | 0.030 |
Why?
|
| Sjogren's Syndrome | 1 | 2016 | 97 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2014 | 12 | 0.030 |
Why?
|
| Scotoma | 1 | 2015 | 15 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2015 | 184 | 0.030 |
Why?
|
| Pharynx | 1 | 1995 | 64 | 0.030 |
Why?
|
| Eye Diseases | 1 | 1996 | 97 | 0.030 |
Why?
|
| Fluorescence | 1 | 1995 | 97 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 291 | 0.030 |
Why?
|
| Prostaglandins F | 1 | 2014 | 9 | 0.030 |
Why?
|
| Genitalia | 1 | 2014 | 38 | 0.030 |
Why?
|
| Vitamin B Complex | 1 | 2015 | 39 | 0.030 |
Why?
|
| Nerve Compression Syndromes | 1 | 1994 | 15 | 0.030 |
Why?
|
| Vision Tests | 1 | 2014 | 23 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2014 | 50 | 0.030 |
Why?
|
| Psychomotor Disorders | 1 | 1994 | 29 | 0.030 |
Why?
|
| Genes, Insect | 1 | 1995 | 112 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 58 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 452 | 0.030 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2014 | 22 | 0.030 |
Why?
|
| Education | 1 | 2015 | 107 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 46 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 518 | 0.030 |
Why?
|
| Telomere Shortening | 1 | 2014 | 34 | 0.030 |
Why?
|
| DNA, Mitochondrial | 2 | 2007 | 233 | 0.030 |
Why?
|
| Visual Perception | 1 | 2015 | 124 | 0.030 |
Why?
|
| Coloboma | 1 | 2014 | 41 | 0.030 |
Why?
|
| Dendrites | 1 | 2015 | 174 | 0.030 |
Why?
|
| Pan troglodytes | 2 | 2006 | 74 | 0.030 |
Why?
|
| Fathers | 1 | 2014 | 70 | 0.030 |
Why?
|
| Genetics, Microbial | 1 | 1993 | 6 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1995 | 192 | 0.030 |
Why?
|
| Diabetes, Gestational | 1 | 1995 | 107 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 215 | 0.030 |
Why?
|
| Joints | 1 | 1993 | 25 | 0.030 |
Why?
|
| Axoneme | 1 | 2013 | 7 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1993 | 8 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 398 | 0.030 |
Why?
|
| Public Health | 1 | 2016 | 269 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 129 | 0.030 |
Why?
|
| Bacillus subtilis | 2 | 1994 | 43 | 0.030 |
Why?
|
| Abdomen | 1 | 2014 | 132 | 0.030 |
Why?
|
| Enzyme Assays | 1 | 2013 | 11 | 0.030 |
Why?
|
| Motor Skills | 1 | 2013 | 76 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 572 | 0.030 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 47 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 69 | 0.030 |
Why?
|
| Bacteriophage mu | 2 | 1985 | 12 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2016 | 323 | 0.020 |
Why?
|
| Penicillin Resistance | 1 | 1993 | 79 | 0.020 |
Why?
|
| PAX6 Transcription Factor | 1 | 2012 | 37 | 0.020 |
Why?
|
| NAV1.4 Voltage-Gated Sodium Channel | 1 | 2012 | 4 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 1993 | 84 | 0.020 |
Why?
|
| Cognition | 1 | 2018 | 784 | 0.020 |
Why?
|
| Radiation Effects | 1 | 2012 | 12 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2012 | 19 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2012 | 75 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2012 | 34 | 0.020 |
Why?
|
| Short Stature Homeobox Protein | 1 | 2012 | 10 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 847 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 49 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 16 | 0.020 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 8 | 0.020 |
Why?
|
| Endoglin | 1 | 2012 | 31 | 0.020 |
Why?
|
| Disclosure | 1 | 2013 | 147 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2012 | 113 | 0.020 |
Why?
|
| Switzerland | 1 | 2012 | 14 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 668 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 91 | 0.020 |
Why?
|
| Aminoacylation | 1 | 2011 | 4 | 0.020 |
Why?
|
| Models, Biological | 2 | 2007 | 1370 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 193 | 0.020 |
Why?
|
| Extremities | 1 | 2012 | 74 | 0.020 |
Why?
|
| Tobacco Products | 1 | 2012 | 60 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 679 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2012 | 71 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 2013 | 203 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1377 | 0.020 |
Why?
|
| Densitometry | 1 | 1991 | 16 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 121 | 0.020 |
Why?
|
| Enterobacteriaceae | 1 | 1991 | 40 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2011 | 31 | 0.020 |
Why?
|
| Models, Statistical | 1 | 1994 | 466 | 0.020 |
Why?
|
| Rhodopsin | 1 | 2011 | 66 | 0.020 |
Why?
|
| Spectrin | 1 | 2012 | 70 | 0.020 |
Why?
|
| DNA, Viral | 2 | 1985 | 448 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2011 | 8 | 0.020 |
Why?
|
| S Phase | 1 | 2011 | 71 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2011 | 30 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 44 | 0.020 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 1991 | 19 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 376 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 156 | 0.020 |
Why?
|
| Australia | 1 | 2011 | 171 | 0.020 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2011 | 22 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2015 | 3586 | 0.020 |
Why?
|
| Osmium Tetroxide | 1 | 1991 | 2 | 0.020 |
Why?
|
| Hydroxylamines | 1 | 1991 | 6 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 1991 | 36 | 0.020 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2011 | 24 | 0.020 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2011 | 6 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 157 | 0.020 |
Why?
|
| Methylation | 1 | 1991 | 196 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2011 | 97 | 0.020 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1990 | 8 | 0.020 |
Why?
|
| Registries | 1 | 2018 | 1536 | 0.020 |
Why?
|
| Research | 1 | 2013 | 253 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 92 | 0.020 |
Why?
|
| Apolipoprotein E4 | 1 | 2011 | 47 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 31 | 0.020 |
Why?
|
| Tetracycline Resistance | 1 | 1990 | 8 | 0.020 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2011 | 17 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 557 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2011 | 73 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 239 | 0.020 |
Why?
|
| Nova Scotia | 1 | 1990 | 3 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2012 | 238 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2015 | 440 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 21 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1991 | 167 | 0.020 |
Why?
|
| Costa Rica | 1 | 2009 | 15 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 1989 | 42 | 0.020 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2009 | 5 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2012 | 200 | 0.020 |
Why?
|
| Autonomic Pathways | 1 | 2008 | 1 | 0.020 |
Why?
|
| Piperidines | 1 | 1991 | 224 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2008 | 34 | 0.020 |
Why?
|
| cis-trans-Isomerases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2008 | 36 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 1090 | 0.020 |
Why?
|
| Jagged-1 Protein | 1 | 2008 | 51 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 2008 | 55 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 2010 | 279 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 108 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 228 | 0.020 |
Why?
|
| Individuality | 1 | 2008 | 37 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1301 | 0.020 |
Why?
|
| Alagille Syndrome | 1 | 2008 | 51 | 0.020 |
Why?
|
| Rod Opsins | 1 | 2007 | 17 | 0.020 |
Why?
|
| Enteric Nervous System | 1 | 2008 | 42 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 1988 | 101 | 0.020 |
Why?
|
| Phosphoinositide Phosphatases | 1 | 2007 | 1 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 2008 | 60 | 0.020 |
Why?
|
| Genetic Drift | 1 | 2007 | 20 | 0.020 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 1 | 2007 | 7 | 0.020 |
Why?
|
| Ulnar Nerve | 2 | 2000 | 10 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2007 | 25 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 1364 | 0.020 |
Why?
|
| Rec A Recombinases | 1 | 2007 | 27 | 0.020 |
Why?
|
| R Factors | 1 | 1987 | 1 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 11 | 0.020 |
Why?
|
| DNA Replication Timing | 1 | 2007 | 11 | 0.020 |
Why?
|
| Genome, Mitochondrial | 1 | 2007 | 29 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2007 | 50 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 327 | 0.020 |
Why?
|
| Haplorhini | 1 | 1987 | 107 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 77 | 0.020 |
Why?
|
| Endodeoxyribonucleases | 1 | 2007 | 44 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2101 | 0.020 |
Why?
|
| Nucleotidyltransferases | 1 | 1987 | 46 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2007 | 124 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 16 | 0.020 |
Why?
|
| snRNP Core Proteins | 1 | 2006 | 8 | 0.020 |
Why?
|
| Sequence Tagged Sites | 2 | 1999 | 27 | 0.020 |
Why?
|
| MARVEL Domain-Containing Proteins | 1 | 2006 | 2 | 0.020 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2006 | 16 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 824 | 0.020 |
Why?
|
| Proteolipids | 1 | 2006 | 6 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 63 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 2007 | 155 | 0.020 |
Why?
|
| Decision Making | 1 | 2011 | 664 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 951 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2012 | 531 | 0.010 |
Why?
|
| Language Disorders | 1 | 2005 | 23 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 452 | 0.010 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2005 | 13 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 320 | 0.010 |
Why?
|
| Autoantigens | 1 | 2006 | 104 | 0.010 |
Why?
|
| Epilepsies, Partial | 1 | 2006 | 84 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 379 | 0.010 |
Why?
|
| Comet Assay | 1 | 2005 | 7 | 0.010 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2005 | 57 | 0.010 |
Why?
|
| DNA Ligase ATP | 1 | 2005 | 11 | 0.010 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2005 | 17 | 0.010 |
Why?
|
| Spain | 1 | 2005 | 60 | 0.010 |
Why?
|
| DNA Ligases | 1 | 2005 | 15 | 0.010 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2005 | 22 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2005 | 75 | 0.010 |
Why?
|
| Coliphages | 1 | 1985 | 4 | 0.010 |
Why?
|
| Cochlea | 1 | 2005 | 88 | 0.010 |
Why?
|
| Peptide Elongation Factors | 1 | 1985 | 12 | 0.010 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2005 | 28 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2005 | 38 | 0.010 |
Why?
|
| Catalysis | 1 | 2005 | 133 | 0.010 |
Why?
|
| Camptothecin | 1 | 2005 | 76 | 0.010 |
Why?
|
| Eyelids | 1 | 2005 | 101 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 302 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 67 | 0.010 |
Why?
|
| Video Recording | 1 | 2006 | 200 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 1987 | 394 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1984 | 59 | 0.010 |
Why?
|
| Blast Crisis | 1 | 2003 | 16 | 0.010 |
Why?
|
| Eukaryotic Cells | 1 | 1984 | 29 | 0.010 |
Why?
|
| Japan | 1 | 2004 | 172 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 298 | 0.010 |
Why?
|
| Nasal Mucosa | 1 | 2004 | 76 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 1984 | 72 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 402 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 309 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1988 | 754 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2006 | 428 | 0.010 |
Why?
|
| Mass Vaccination | 1 | 2002 | 13 | 0.010 |
Why?
|
| Aqueous Humor | 1 | 2002 | 15 | 0.010 |
Why?
|
| Israel | 1 | 2002 | 48 | 0.010 |
Why?
|
| Ciliary Body | 1 | 2002 | 18 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 2005 | 402 | 0.010 |
Why?
|
| Newfoundland and Labrador | 1 | 2002 | 1 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 39 | 0.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 28 | 0.010 |
Why?
|
| Connexin 26 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Auditory Threshold | 1 | 2002 | 15 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2002 | 49 | 0.010 |
Why?
|
| Dark Adaptation | 1 | 2002 | 33 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 2005 | 366 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2006 | 550 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 2001 | 4 | 0.010 |
Why?
|
| Sulfotransferases | 1 | 2001 | 25 | 0.010 |
Why?
|
| Cebidae | 1 | 2001 | 4 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2005 | 870 | 0.010 |
Why?
|
| Bacteremia | 1 | 2005 | 420 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 171 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2002 | 379 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 756 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2002 | 223 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 125 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2005 | 775 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 986 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2001 | 480 | 0.010 |
Why?
|
| Triglycerides | 1 | 2002 | 596 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 1999 | 50 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 1559 | 0.010 |
Why?
|
| Salmonella Phages | 1 | 1998 | 2 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2002 | 604 | 0.010 |
Why?
|
| Retinal Drusen | 1 | 1997 | 4 | 0.010 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1997 | 36 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 3251 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1983 | 988 | 0.010 |
Why?
|
| Middle East | 1 | 1997 | 36 | 0.010 |
Why?
|
| Iris Diseases | 1 | 1996 | 10 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1996 | 103 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2002 | 1654 | 0.010 |
Why?
|
| Strabismus | 1 | 1996 | 41 | 0.010 |
Why?
|
| Corneal Diseases | 1 | 1996 | 78 | 0.010 |
Why?
|
| Colforsin | 1 | 1994 | 45 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1994 | 113 | 0.010 |
Why?
|
| Nerve Regeneration | 1 | 1994 | 71 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1992 | 48 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1991 | 291 | 0.010 |
Why?
|
| Action Potentials | 1 | 1993 | 463 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1993 | 826 | 0.000 |
Why?
|
| Transcriptional Elongation Factors | 1 | 1985 | 24 | 0.000 |
Why?
|
| Codon | 1 | 1982 | 95 | 0.000 |
Why?
|
| Lac Operon | 1 | 1981 | 90 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1982 | 756 | 0.000 |
Why?
|